| ENSG00000185044.10 |
PF-562271 |
Bladder urothelial carcinoma |
0.007174785 |
Resistant |
| ENSG00000203801.4 |
PF-562271 |
Bladder urothelial carcinoma |
0.005526486 |
Resistant |
| ENSG00000205628.2 |
PF-562271 |
Bladder urothelial carcinoma |
0.038546553 |
Resistant |
| ENSG00000224271.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.007800522 |
Resistant |
| ENSG00000225541.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.030492936 |
Resistant |
| ENSG00000229728.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.006059428 |
Resistant |
| ENSG00000230880.2 |
PF-562271 |
Bladder urothelial carcinoma |
0.038794743 |
Resistant |
| ENSG00000232533.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.017839635 |
Resistant |
| ENSG00000232759.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.025272116 |
Resistant |
| ENSG00000233825.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.012492646 |
Resistant |
| ENSG00000234684.2 |
PF-562271 |
Bladder urothelial carcinoma |
0.024758685 |
Resistant |
| ENSG00000237291.2 |
PF-562271 |
Bladder urothelial carcinoma |
0.002081214 |
Resistant |
| ENSG00000242569.3 |
PF-562271 |
Bladder urothelial carcinoma |
0.024924095 |
Resistant |
| ENSG00000246130.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.040141439 |
Resistant |
| ENSG00000246523.3 |
PF-562271 |
Bladder urothelial carcinoma |
0.029998532 |
Resistant |
| ENSG00000246560.2 |
PF-562271 |
Bladder urothelial carcinoma |
0.045190987 |
Resistant |
| ENSG00000253829.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.035060801 |
Resistant |
| ENSG00000257381.2 |
PF-562271 |
Bladder urothelial carcinoma |
0.004652596 |
Resistant |
| ENSG00000260955.2 |
PF-562271 |
Bladder urothelial carcinoma |
0.04949627 |
Resistant |
| ENSG00000261775.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.015898405 |
Resistant |
| ENSG00000263050.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.008738339 |
Resistant |
| ENSG00000264456.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.01546238 |
Resistant |
| ENSG00000265010.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.00717115 |
Resistant |
| ENSG00000266304.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.019529312 |
Resistant |
| ENSG00000266783.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.037055797 |
Resistant |
| ENSG00000267284.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.023353061 |
Resistant |
| ENSG00000270103.2 |
PF-562271 |
Bladder urothelial carcinoma |
0.033599959 |
Resistant |
| ENSG00000271926.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.018598402 |
Resistant |
| ENSG00000272273.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.001525291 |
Resistant |
| ENSG00000273353.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.037909634 |
Resistant |
| ENSG00000182165.13 |
PF-562271 |
Breast invasive carcinoma |
0.027096356 |
Resistant |
| ENSG00000186056.5 |
PF-562271 |
Breast invasive carcinoma |
0.012458326 |
Resistant |
| ENSG00000204241.3 |
PF-562271 |
Breast invasive carcinoma |
0.011297954 |
Resistant |
| ENSG00000205634.2 |
PF-562271 |
Breast invasive carcinoma |
0.041719076 |
Resistant |
| ENSG00000215256.3 |
PF-562271 |
Breast invasive carcinoma |
0.041770001 |
Resistant |
| ENSG00000224271.1 |
PF-562271 |
Breast invasive carcinoma |
0.019098583 |
Resistant |
| ENSG00000224660.1 |
PF-562271 |
Breast invasive carcinoma |
0.026715608 |
Resistant |
| ENSG00000225595.2 |
PF-562271 |
Breast invasive carcinoma |
0.047752287 |
Resistant |
| ENSG00000227107.1 |
PF-562271 |
Breast invasive carcinoma |
0.033942736 |
Resistant |
| ENSG00000227617.4 |
PF-562271 |
Breast invasive carcinoma |
0.038659018 |
Resistant |
| ENSG00000230212.2 |
PF-562271 |
Breast invasive carcinoma |
0.013957004 |
Resistant |
| ENSG00000231401.1 |
PF-562271 |
Breast invasive carcinoma |
0.043409151 |
Resistant |
| ENSG00000232470.1 |
PF-562271 |
Breast invasive carcinoma |
0.037519649 |
Resistant |
| ENSG00000232504.4 |
PF-562271 |
Breast invasive carcinoma |
0.017954223 |
Resistant |
| ENSG00000234437.1 |
PF-562271 |
Breast invasive carcinoma |
0.041422616 |
Resistant |
| ENSG00000234818.1 |
PF-562271 |
Breast invasive carcinoma |
0.032303909 |
Resistant |
| ENSG00000235296.1 |
PF-562271 |
Breast invasive carcinoma |
0.020301881 |
Resistant |
| ENSG00000236830.2 |
PF-562271 |
Breast invasive carcinoma |
0.010158232 |
Resistant |
| ENSG00000237181.1 |
PF-562271 |
Breast invasive carcinoma |
0.03509135 |
Resistant |
| ENSG00000237689.1 |
PF-562271 |
Breast invasive carcinoma |
0.037055575 |
Resistant |
| ENSG00000238184.1 |
PF-562271 |
Breast invasive carcinoma |
0.010715694 |
Resistant |
| ENSG00000241288.3 |
PF-562271 |
Breast invasive carcinoma |
0.037929145 |
Resistant |
| ENSG00000246422.2 |
PF-562271 |
Breast invasive carcinoma |
0.043155841 |
Resistant |
| ENSG00000247970.2 |
PF-562271 |
Breast invasive carcinoma |
0.044816505 |
Resistant |
| ENSG00000248787.1 |
PF-562271 |
Breast invasive carcinoma |
0.033518276 |
Resistant |
| ENSG00000250170.1 |
PF-562271 |
Breast invasive carcinoma |
0.012949923 |
Resistant |
| ENSG00000250616.2 |
PF-562271 |
Breast invasive carcinoma |
0.038763059 |
Resistant |
| ENSG00000257696.1 |
PF-562271 |
Breast invasive carcinoma |
0.030775777 |
Resistant |
| ENSG00000258731.1 |
PF-562271 |
Breast invasive carcinoma |
0.009944628 |
Resistant |
| ENSG00000259343.1 |
PF-562271 |
Breast invasive carcinoma |
0.012118704 |
Resistant |
| ENSG00000259793.1 |
PF-562271 |
Breast invasive carcinoma |
0.03678463 |
Resistant |
| ENSG00000260132.1 |
PF-562271 |
Breast invasive carcinoma |
0.047310804 |
Resistant |
| ENSG00000260541.1 |
PF-562271 |
Breast invasive carcinoma |
0.033286886 |
Resistant |
| ENSG00000260693.1 |
PF-562271 |
Breast invasive carcinoma |
0.038092914 |
Resistant |
| ENSG00000262921.1 |
PF-562271 |
Breast invasive carcinoma |
0.042827123 |
Resistant |
| ENSG00000263063.1 |
PF-562271 |
Breast invasive carcinoma |
0.044927605 |
Resistant |
| ENSG00000263105.1 |
PF-562271 |
Breast invasive carcinoma |
0.025384296 |
Resistant |
| ENSG00000264491.1 |
PF-562271 |
Breast invasive carcinoma |
0.025047371 |
Resistant |
| ENSG00000265787.1 |
PF-562271 |
Breast invasive carcinoma |
0.04405329 |
Resistant |
| ENSG00000267042.1 |
PF-562271 |
Breast invasive carcinoma |
0.044906808 |
Resistant |
| ENSG00000267388.1 |
PF-562271 |
Breast invasive carcinoma |
0.04080358 |
Resistant |
| ENSG00000270000.1 |
PF-562271 |
Breast invasive carcinoma |
0.048809268 |
Resistant |
| ENSG00000272172.1 |
PF-562271 |
Breast invasive carcinoma |
0.002019869 |
Resistant |
| ENSG00000273270.1 |
PF-562271 |
Breast invasive carcinoma |
0.040848066 |
Resistant |
| ENSG00000273456.1 |
PF-562271 |
Breast invasive carcinoma |
0.032693493 |
Resistant |
| ENSG00000132832.5 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.025490355 |
Resistant |
| ENSG00000203650.3 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.017384286 |
Resistant |
| ENSG00000214184.3 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.026962316 |
Resistant |
| ENSG00000214894.2 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.041918613 |
Resistant |
| ENSG00000223695.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.027734818 |
Resistant |
| ENSG00000224020.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.042314103 |
Resistant |
| ENSG00000224939.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.038572659 |
Resistant |
| ENSG00000225335.2 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.045497485 |
Resistant |
| ENSG00000225778.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.038340225 |
Resistant |
| ENSG00000227060.2 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.030521707 |
Resistant |
| ENSG00000230337.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.038178189 |
Resistant |
| ENSG00000230899.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.023778135 |
Resistant |
| ENSG00000231441.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.028074152 |
Resistant |
| ENSG00000231638.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.018930389 |
Resistant |
| ENSG00000231840.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.006497978 |
Resistant |
| ENSG00000233237.2 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.001030797 |
Resistant |
| ENSG00000234978.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.028075976 |
Resistant |
| ENSG00000235770.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.035995467 |
Resistant |
| ENSG00000235831.2 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.041337555 |
Resistant |
| ENSG00000236098.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.038833582 |
Resistant |
| ENSG00000236345.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.015115855 |
Resistant |
| ENSG00000237721.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.041504674 |
Resistant |
| ENSG00000240211.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.037521018 |
Resistant |
| ENSG00000243176.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.000621109 |
Resistant |
| ENSG00000254231.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.032574295 |
Resistant |
| ENSG00000259062.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.023594302 |
Resistant |
| ENSG00000261040.2 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.009777992 |
Resistant |
| ENSG00000261644.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.028318262 |
Resistant |
| ENSG00000261824.2 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.023428116 |
Resistant |
| ENSG00000262185.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.004026571 |
Resistant |
| ENSG00000266970.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.004745427 |
Resistant |
| ENSG00000267308.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.049704115 |
Resistant |
| ENSG00000270000.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.048170925 |
Resistant |
| ENSG00000271849.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.007407728 |
Resistant |
| ENSG00000272043.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.026342974 |
Resistant |
| ENSG00000272275.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.046984383 |
Resistant |
| ENSG00000213468.3 |
PF-562271 |
Colon adenocarcinoma |
0.032564831 |
Resistant |
| ENSG00000224687.1 |
PF-562271 |
Colon adenocarcinoma |
0.049673889 |
Resistant |
| ENSG00000225945.1 |
PF-562271 |
Colon adenocarcinoma |
0.027417822 |
Resistant |
| ENSG00000227630.2 |
PF-562271 |
Colon adenocarcinoma |
0.03590995 |
Resistant |
| ENSG00000229368.1 |
PF-562271 |
Colon adenocarcinoma |
0.036854024 |
Resistant |
| ENSG00000231704.1 |
PF-562271 |
Colon adenocarcinoma |
0.031114217 |
Resistant |
| ENSG00000232527.3 |
PF-562271 |
Colon adenocarcinoma |
0.033533625 |
Resistant |
| ENSG00000233427.1 |
PF-562271 |
Colon adenocarcinoma |
0.008267584 |
Resistant |
| ENSG00000235806.1 |
PF-562271 |
Colon adenocarcinoma |
0.024487478 |
Resistant |
| ENSG00000244198.1 |
PF-562271 |
Colon adenocarcinoma |
0.047379792 |
Resistant |
| ENSG00000244300.2 |
PF-562271 |
Colon adenocarcinoma |
0.043542566 |
Resistant |
| ENSG00000248846.2 |
PF-562271 |
Colon adenocarcinoma |
0.036355127 |
Resistant |
| ENSG00000250786.1 |
PF-562271 |
Colon adenocarcinoma |
0.031605006 |
Resistant |
| ENSG00000253898.1 |
PF-562271 |
Colon adenocarcinoma |
0.005444711 |
Resistant |
| ENSG00000255052.3 |
PF-562271 |
Colon adenocarcinoma |
0.032223957 |
Resistant |
| ENSG00000261189.1 |
PF-562271 |
Colon adenocarcinoma |
0.03908193 |
Resistant |
| ENSG00000261712.1 |
PF-562271 |
Colon adenocarcinoma |
0.003508006 |
Resistant |
| ENSG00000263753.2 |
PF-562271 |
Colon adenocarcinoma |
0.007041701 |
Resistant |
| ENSG00000264575.1 |
PF-562271 |
Colon adenocarcinoma |
0.006317134 |
Resistant |
| ENSG00000265091.1 |
PF-562271 |
Colon adenocarcinoma |
0.012666483 |
Resistant |
| ENSG00000267852.1 |
PF-562271 |
Colon adenocarcinoma |
0.046366543 |
Resistant |
| ENSG00000270170.1 |
PF-562271 |
Colon adenocarcinoma |
0.039899436 |
Resistant |
| ENSG00000272079.1 |
PF-562271 |
Colon adenocarcinoma |
0.044250983 |
Resistant |
| ENSG00000203875.6 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026569193 |
Resistant |
| ENSG00000205662.2 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037473474 |
Resistant |
| ENSG00000214184.3 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039105121 |
Resistant |
| ENSG00000215458.4 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043688955 |
Resistant |
| ENSG00000224468.3 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002356856 |
Resistant |
| ENSG00000224846.1 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015482249 |
Resistant |
| ENSG00000225213.2 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023803533 |
Resistant |
| ENSG00000228554.1 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036627229 |
Resistant |
| ENSG00000230107.1 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042916567 |
Resistant |
| ENSG00000231193.1 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038882854 |
Resistant |
| ENSG00000233330.1 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047275767 |
Resistant |
| ENSG00000234449.2 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035558931 |
Resistant |
| ENSG00000234789.1 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.0476043 |
Resistant |
| ENSG00000237298.4 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031624552 |
Resistant |
| ENSG00000237424.1 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03499687 |
Resistant |
| ENSG00000237903.1 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015630453 |
Resistant |
| ENSG00000244676.1 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049349337 |
Resistant |
| ENSG00000254839.1 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036141541 |
Resistant |
| ENSG00000255094.1 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.0304944 |
Resistant |
| ENSG00000256299.1 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036035364 |
Resistant |
| ENSG00000259758.1 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033129787 |
Resistant |
| ENSG00000260816.1 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036687665 |
Resistant |
| ENSG00000264608.1 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007455504 |
Resistant |
| ENSG00000267734.1 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041277215 |
Resistant |
| ENSG00000269365.1 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043249476 |
Resistant |
| ENSG00000270681.1 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020302125 |
Resistant |
| ENSG00000271835.1 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030419457 |
Resistant |
| ENSG00000172250.10 |
PF-562271 |
Esophageal cancer |
0.015491162 |
Resistant |
| ENSG00000177738.3 |
PF-562271 |
Esophageal cancer |
0.02130411 |
Resistant |
| ENSG00000181097.5 |
PF-562271 |
Esophageal cancer |
0.035358933 |
Resistant |
| ENSG00000203496.4 |
PF-562271 |
Esophageal cancer |
0.03887577 |
Resistant |
| ENSG00000204837.2 |
PF-562271 |
Esophageal cancer |
0.048481103 |
Resistant |
| ENSG00000215256.3 |
PF-562271 |
Esophageal cancer |
0.03309169 |
Resistant |
| ENSG00000215808.2 |
PF-562271 |
Esophageal cancer |
0.043182751 |
Resistant |
| ENSG00000223935.1 |
PF-562271 |
Esophageal cancer |
0.001485698 |
Resistant |
| ENSG00000225914.1 |
PF-562271 |
Esophageal cancer |
0.04210654 |
Resistant |
| ENSG00000226328.2 |
PF-562271 |
Esophageal cancer |
0.020000297 |
Resistant |
| ENSG00000226851.1 |
PF-562271 |
Esophageal cancer |
0.04587675 |
Resistant |
| ENSG00000226856.1 |
PF-562271 |
Esophageal cancer |
0.043238039 |
Resistant |
| ENSG00000227071.1 |
PF-562271 |
Esophageal cancer |
0.018098585 |
Resistant |
| ENSG00000227741.1 |
PF-562271 |
Esophageal cancer |
0.034886838 |
Resistant |
| ENSG00000228889.2 |
PF-562271 |
Esophageal cancer |
0.035197027 |
Resistant |
| ENSG00000230068.2 |
PF-562271 |
Esophageal cancer |
0.046913117 |
Resistant |
| ENSG00000231028.4 |
PF-562271 |
Esophageal cancer |
0.016959614 |
Resistant |
| ENSG00000231242.1 |
PF-562271 |
Esophageal cancer |
0.01919012 |
Resistant |
| ENSG00000231806.2 |
PF-562271 |
Esophageal cancer |
0.012220955 |
Resistant |
| ENSG00000233013.4 |
PF-562271 |
Esophageal cancer |
0.018337918 |
Resistant |
| ENSG00000233137.2 |
PF-562271 |
Esophageal cancer |
0.022748711 |
Resistant |
| ENSG00000233483.2 |
PF-562271 |
Esophageal cancer |
0.008795452 |
Resistant |
| ENSG00000234492.4 |
PF-562271 |
Esophageal cancer |
0.040538415 |
Resistant |
| ENSG00000234695.1 |
PF-562271 |
Esophageal cancer |
0.010296705 |
Resistant |
| ENSG00000235072.1 |
PF-562271 |
Esophageal cancer |
0.005663663 |
Resistant |
| ENSG00000235159.1 |
PF-562271 |
Esophageal cancer |
0.00873559 |
Resistant |
| ENSG00000236305.1 |
PF-562271 |
Esophageal cancer |
0.028792332 |
Resistant |
| ENSG00000236618.2 |
PF-562271 |
Esophageal cancer |
0.016293518 |
Resistant |
| ENSG00000236751.1 |
PF-562271 |
Esophageal cancer |
0.012304633 |
Resistant |
| ENSG00000237429.1 |
PF-562271 |
Esophageal cancer |
0.012108215 |
Resistant |
| ENSG00000240618.1 |
PF-562271 |
Esophageal cancer |
0.018339041 |
Resistant |
| ENSG00000241860.2 |
PF-562271 |
Esophageal cancer |
0.034743769 |
Resistant |
| ENSG00000244055.1 |
PF-562271 |
Esophageal cancer |
0.035951616 |
Resistant |
| ENSG00000246067.3 |
PF-562271 |
Esophageal cancer |
0.049504882 |
Resistant |
| ENSG00000249207.1 |
PF-562271 |
Esophageal cancer |
0.036036109 |
Resistant |
| ENSG00000249383.1 |
PF-562271 |
Esophageal cancer |
0.025069406 |
Resistant |
| ENSG00000249417.1 |
PF-562271 |
Esophageal cancer |
0.041409882 |
Resistant |
| ENSG00000250802.2 |
PF-562271 |
Esophageal cancer |
0.029032025 |
Resistant |
| ENSG00000250950.1 |
PF-562271 |
Esophageal cancer |
0.049292977 |
Resistant |
| ENSG00000251131.1 |
PF-562271 |
Esophageal cancer |
0.013775126 |
Resistant |
| ENSG00000251364.2 |
PF-562271 |
Esophageal cancer |
0.038591269 |
Resistant |
| ENSG00000253263.1 |
PF-562271 |
Esophageal cancer |
0.00575881 |
Resistant |
| ENSG00000253315.1 |
PF-562271 |
Esophageal cancer |
0.026734501 |
Resistant |
| ENSG00000253608.1 |
PF-562271 |
Esophageal cancer |
0.039313327 |
Resistant |
| ENSG00000255158.1 |
PF-562271 |
Esophageal cancer |
0.015750735 |
Resistant |
| ENSG00000255503.1 |
PF-562271 |
Esophageal cancer |
0.036668442 |
Resistant |
| ENSG00000257052.1 |
PF-562271 |
Esophageal cancer |
0.023028491 |
Resistant |
| ENSG00000257176.1 |
PF-562271 |
Esophageal cancer |
0.020235648 |
Resistant |
| ENSG00000257391.1 |
PF-562271 |
Esophageal cancer |
0.005482937 |
Resistant |
| ENSG00000257563.1 |
PF-562271 |
Esophageal cancer |
0.01154945 |
Resistant |
| ENSG00000257913.1 |
PF-562271 |
Esophageal cancer |
0.024888506 |
Resistant |
| ENSG00000258057.1 |
PF-562271 |
Esophageal cancer |
0.048433827 |
Resistant |
| ENSG00000258457.1 |
PF-562271 |
Esophageal cancer |
0.045195091 |
Resistant |
| ENSG00000260336.1 |
PF-562271 |
Esophageal cancer |
0.014236473 |
Resistant |
| ENSG00000260604.1 |
PF-562271 |
Esophageal cancer |
0.023401178 |
Resistant |
| ENSG00000260625.1 |
PF-562271 |
Esophageal cancer |
0.004072158 |
Resistant |
| ENSG00000260647.1 |
PF-562271 |
Esophageal cancer |
0.048421054 |
Resistant |
| ENSG00000260884.1 |
PF-562271 |
Esophageal cancer |
0.000452201 |
Resistant |
| ENSG00000261437.1 |
PF-562271 |
Esophageal cancer |
0.048271936 |
Resistant |
| ENSG00000261799.1 |
PF-562271 |
Esophageal cancer |
0.025055229 |
Resistant |
| ENSG00000262966.2 |
PF-562271 |
Esophageal cancer |
0.005572221 |
Resistant |
| ENSG00000263272.1 |
PF-562271 |
Esophageal cancer |
0.01399408 |
Resistant |
| ENSG00000264729.1 |
PF-562271 |
Esophageal cancer |
0.035441041 |
Resistant |
| ENSG00000266999.1 |
PF-562271 |
Esophageal cancer |
0.041058579 |
Resistant |
| ENSG00000267288.1 |
PF-562271 |
Esophageal cancer |
0.03673739 |
Resistant |
| ENSG00000267419.1 |
PF-562271 |
Esophageal cancer |
0.020851461 |
Resistant |
| ENSG00000269921.1 |
PF-562271 |
Esophageal cancer |
0.002220617 |
Resistant |
| ENSG00000270604.1 |
PF-562271 |
Esophageal cancer |
0.043107611 |
Resistant |
| ENSG00000270996.1 |
PF-562271 |
Esophageal cancer |
0.03154224 |
Resistant |
| ENSG00000271259.1 |
PF-562271 |
Esophageal cancer |
0.045197989 |
Resistant |
| ENSG00000272023.1 |
PF-562271 |
Esophageal cancer |
0.033567089 |
Resistant |
| ENSG00000272885.1 |
PF-562271 |
Esophageal cancer |
0.010840073 |
Resistant |
| ENSG00000273145.1 |
PF-562271 |
Esophageal cancer |
0.046995705 |
Resistant |
| ENSG00000273328.1 |
PF-562271 |
Esophageal cancer |
0.015198472 |
Resistant |
| ENSG00000172965.10 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.043459029 |
Resistant |
| ENSG00000189196.4 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.005553668 |
Resistant |
| ENSG00000203364.2 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.001451223 |
Resistant |
| ENSG00000204044.5 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.028599871 |
Resistant |
| ENSG00000204792.2 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.044092817 |
Resistant |
| ENSG00000205054.2 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.000336101 |
Resistant |
| ENSG00000223749.3 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.004466283 |
Resistant |
| ENSG00000223784.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.04985605 |
Resistant |
| ENSG00000226332.2 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.0110151 |
Resistant |
| ENSG00000227908.3 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.027988913 |
Resistant |
| ENSG00000228221.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.014897511 |
Resistant |
| ENSG00000228719.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.036966117 |
Resistant |
| ENSG00000229382.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.037434569 |
Resistant |
| ENSG00000230333.2 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.041224649 |
Resistant |
| ENSG00000230534.2 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.028685923 |
Resistant |
| ENSG00000231154.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.008803483 |
Resistant |
| ENSG00000231512.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.040076939 |
Resistant |
| ENSG00000231806.2 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.016849439 |
Resistant |
| ENSG00000232725.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.028046701 |
Resistant |
| ENSG00000233242.2 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.017912749 |
Resistant |
| ENSG00000234183.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.011638813 |
Resistant |
| ENSG00000234232.2 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.049365937 |
Resistant |
| ENSG00000234936.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.021854188 |
Resistant |
| ENSG00000235358.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.003432354 |
Resistant |
| ENSG00000237184.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.007036801 |
Resistant |
| ENSG00000239445.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.043781836 |
Resistant |
| ENSG00000246877.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.018152478 |
Resistant |
| ENSG00000247675.2 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.036954223 |
Resistant |
| ENSG00000247765.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.006477713 |
Resistant |
| ENSG00000248309.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.045095266 |
Resistant |
| ENSG00000249084.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.046017323 |
Resistant |
| ENSG00000249595.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.011209104 |
Resistant |
| ENSG00000250786.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.047608256 |
Resistant |
| ENSG00000251003.3 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.010931748 |
Resistant |
| ENSG00000253636.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.048722878 |
Resistant |
| ENSG00000253716.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.042514203 |
Resistant |
| ENSG00000253961.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.045884919 |
Resistant |
| ENSG00000254860.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.04555253 |
Resistant |
| ENSG00000254885.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.013591593 |
Resistant |
| ENSG00000255237.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.040049315 |
Resistant |
| ENSG00000258704.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.043614559 |
Resistant |
| ENSG00000259274.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.048590329 |
Resistant |
| ENSG00000260186.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.016882724 |
Resistant |
| ENSG00000260285.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.001827381 |
Resistant |
| ENSG00000260366.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.031956338 |
Resistant |
| ENSG00000260409.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.008610145 |
Resistant |
| ENSG00000260467.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.014069225 |
Resistant |
| ENSG00000260526.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.001200701 |
Resistant |
| ENSG00000260708.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.025564979 |
Resistant |
| ENSG00000260874.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.042798514 |
Resistant |
| ENSG00000260924.2 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.029852693 |
Resistant |
| ENSG00000261173.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.031384133 |
Resistant |
| ENSG00000261186.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.042159924 |
Resistant |
| ENSG00000261431.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.020006906 |
Resistant |
| ENSG00000262580.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.018094851 |
Resistant |
| ENSG00000263063.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.018278018 |
Resistant |
| ENSG00000264125.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.004801557 |
Resistant |
| ENSG00000264196.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.004880764 |
Resistant |
| ENSG00000264672.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.016665223 |
Resistant |
| ENSG00000267546.2 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.028758448 |
Resistant |
| ENSG00000267667.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.0052968 |
Resistant |
| ENSG00000270157.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.008217099 |
Resistant |
| ENSG00000270673.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.034904681 |
Resistant |
| ENSG00000271659.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.021715181 |
Resistant |
| ENSG00000271888.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.013715933 |
Resistant |
| ENSG00000271912.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.021087363 |
Resistant |
| ENSG00000272205.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.049711179 |
Resistant |
| ENSG00000272866.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.04180242 |
Resistant |
| ENSG00000273253.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.049324596 |
Resistant |
| ENSG00000273474.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.044279945 |
Resistant |
| ENSG00000088970.11 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.009591029 |
Resistant |
| ENSG00000177406.4 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.049722489 |
Resistant |
| ENSG00000179859.7 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.011380505 |
Resistant |
| ENSG00000182366.5 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.042050064 |
Resistant |
| ENSG00000189223.9 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.017035633 |
Resistant |
| ENSG00000197670.5 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.049635943 |
Resistant |
| ENSG00000206142.5 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.027408581 |
Resistant |
| ENSG00000223380.3 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.018331083 |
Resistant |
| ENSG00000223442.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.024262818 |
Resistant |
| ENSG00000223711.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.032157615 |
Resistant |
| ENSG00000223745.3 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.016648422 |
Resistant |
| ENSG00000224505.2 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.004833668 |
Resistant |
| ENSG00000224812.2 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.018186092 |
Resistant |
| ENSG00000224972.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.025648143 |
Resistant |
| ENSG00000225292.2 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.027449643 |
Resistant |
| ENSG00000225353.2 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.023283181 |
Resistant |
| ENSG00000225579.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.010804066 |
Resistant |
| ENSG00000225675.2 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.019803831 |
Resistant |
| ENSG00000225762.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.025176903 |
Resistant |
| ENSG00000225839.2 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.02484674 |
Resistant |
| ENSG00000225886.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.010779748 |
Resistant |
| ENSG00000225891.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.046741457 |
Resistant |
| ENSG00000225963.3 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.042361048 |
Resistant |
| ENSG00000225986.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.012413109 |
Resistant |
| ENSG00000226167.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.044961735 |
Resistant |
| ENSG00000226416.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.021355769 |
Resistant |
| ENSG00000226472.3 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.026145817 |
Resistant |
| ENSG00000226877.3 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.026034409 |
Resistant |
| ENSG00000227083.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.036967715 |
Resistant |
| ENSG00000227161.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.035090333 |
Resistant |
| ENSG00000227172.2 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.034220255 |
Resistant |
| ENSG00000227533.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.047513984 |
Resistant |
| ENSG00000227627.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.027348032 |
Resistant |
| ENSG00000228436.2 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.02194858 |
Resistant |
| ENSG00000228554.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.013005401 |
Resistant |
| ENSG00000228686.2 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.040282709 |
Resistant |
| ENSG00000228863.4 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.031048078 |
Resistant |
| ENSG00000229331.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.021868517 |
Resistant |
| ENSG00000229776.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.045427113 |
Resistant |
| ENSG00000230084.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.049375409 |
Resistant |
| ENSG00000230138.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.016033334 |
Resistant |
| ENSG00000230684.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.038229046 |
Resistant |
| ENSG00000230789.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.026687291 |
Resistant |
| ENSG00000230790.2 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.01381166 |
Resistant |
| ENSG00000230881.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.033268628 |
Resistant |
| ENSG00000231104.4 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.009093391 |
Resistant |
| ENSG00000231233.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.029948953 |
Resistant |
| ENSG00000231242.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.004557855 |
Resistant |
| ENSG00000231294.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.044104468 |
Resistant |
| ENSG00000231473.2 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.013986924 |
Resistant |
| ENSG00000231509.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.025693565 |
Resistant |
| ENSG00000231527.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.031556476 |
Resistant |
| ENSG00000231530.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.021426111 |
Resistant |
| ENSG00000231616.4 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.03467948 |
Resistant |
| ENSG00000231636.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.040880889 |
Resistant |
| ENSG00000232043.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.043540642 |
Resistant |
| ENSG00000232098.2 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.00433389 |
Resistant |
| ENSG00000232363.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.033386438 |
Resistant |
| ENSG00000232686.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.043454844 |
Resistant |
| ENSG00000233033.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.023731759 |
Resistant |
| ENSG00000233137.2 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.006586166 |
Resistant |
| ENSG00000233178.3 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.030886534 |
Resistant |
| ENSG00000233184.2 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.036537035 |
Resistant |
| ENSG00000233651.2 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.030742567 |
Resistant |
| ENSG00000234028.3 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.041982181 |
Resistant |
| ENSG00000234141.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.041027295 |
Resistant |
| ENSG00000234290.2 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.03777171 |
Resistant |
| ENSG00000234393.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.00680772 |
Resistant |
| ENSG00000235652.3 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.0000463 |
Resistant |
| ENSG00000236017.3 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.016558721 |
Resistant |
| ENSG00000236066.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.029163275 |
Resistant |
| ENSG00000236088.5 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.025286755 |
Resistant |
| ENSG00000236234.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.032471377 |
Resistant |
| ENSG00000236434.2 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.02831687 |
Resistant |
| ENSG00000236559.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.014616954 |
Resistant |
| ENSG00000236753.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.012985537 |
Resistant |
| ENSG00000236871.2 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.021813613 |
Resistant |
| ENSG00000236935.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.030571814 |
Resistant |
| ENSG00000237036.4 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.031445543 |
Resistant |
| ENSG00000237424.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.035122638 |
Resistant |
| ENSG00000237485.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.023567123 |
Resistant |
| ENSG00000237505.2 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.025523855 |
Resistant |
| ENSG00000238039.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.031935113 |
Resistant |
| ENSG00000238198.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.009305878 |
Resistant |
| ENSG00000238224.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.022405144 |
Resistant |
| ENSG00000239335.4 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.04536659 |
Resistant |
| ENSG00000240254.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.047136035 |
Resistant |
| ENSG00000240549.2 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.025986963 |
Resistant |
| ENSG00000240553.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.02738908 |
Resistant |
| ENSG00000240996.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.001949272 |
Resistant |
| ENSG00000241014.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.048419768 |
Resistant |
| ENSG00000242628.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.002216633 |
Resistant |
| ENSG00000243055.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.008423457 |
Resistant |
| ENSG00000243224.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.008654906 |
Resistant |
| ENSG00000244124.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.029084502 |
Resistant |
| ENSG00000244345.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.039233839 |
Resistant |
| ENSG00000244558.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.031375374 |
Resistant |
| ENSG00000245571.2 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.013002569 |
Resistant |
| ENSG00000245849.2 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.02640533 |
Resistant |
| ENSG00000245937.3 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.007902121 |
Resistant |
| ENSG00000247157.2 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.033257068 |
Resistant |
| ENSG00000248221.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.036843428 |
Resistant |
| ENSG00000248544.2 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.023508891 |
Resistant |
| ENSG00000248734.2 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.023789432 |
Resistant |
| ENSG00000248980.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.037604632 |
Resistant |
| ENSG00000249993.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.021572185 |
Resistant |
| ENSG00000250015.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.008625428 |
Resistant |
| ENSG00000251034.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.029765803 |
Resistant |
| ENSG00000251405.2 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.032480753 |
Resistant |
| ENSG00000253174.2 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.028720467 |
Resistant |
| ENSG00000253632.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.035657988 |
Resistant |
| ENSG00000253824.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.03375576 |
Resistant |
| ENSG00000253829.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.019822602 |
Resistant |
| ENSG00000253961.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.002620529 |
Resistant |
| ENSG00000253965.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.03329239 |
Resistant |
| ENSG00000254034.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.007813211 |
Resistant |
| ENSG00000254461.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.033210745 |
Resistant |
| ENSG00000254538.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.019572251 |
Resistant |
| ENSG00000254539.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.020729406 |
Resistant |
| ENSG00000254577.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.007712207 |
Resistant |
| ENSG00000254632.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.042893674 |
Resistant |
| ENSG00000254662.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.007281266 |
Resistant |
| ENSG00000254814.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.02381611 |
Resistant |
| ENSG00000254910.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.015353826 |
Resistant |
| ENSG00000254966.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.024069481 |
Resistant |
| ENSG00000255089.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.028759798 |
Resistant |
| ENSG00000255142.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.038892381 |
Resistant |
| ENSG00000255148.2 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.004411322 |
Resistant |
| ENSG00000255421.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.037958121 |
Resistant |
| ENSG00000255458.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.02419086 |
Resistant |
| ENSG00000255539.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.024778915 |
Resistant |
| ENSG00000255557.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.040086899 |
Resistant |
| ENSG00000255670.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.001634345 |
Resistant |
| ENSG00000255847.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.049150612 |
Resistant |
| ENSG00000255970.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.040886652 |
Resistant |
| ENSG00000256008.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.017160872 |
Resistant |
| ENSG00000256124.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.023651078 |
Resistant |
| ENSG00000257027.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.006111887 |
Resistant |
| ENSG00000257058.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.029873933 |
Resistant |
| ENSG00000257496.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.02851448 |
Resistant |
| ENSG00000257696.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.013479769 |
Resistant |
| ENSG00000258044.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.00203163 |
Resistant |
| ENSG00000258048.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.02867722 |
Resistant |
| ENSG00000258057.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.004396228 |
Resistant |
| ENSG00000258102.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.018489563 |
Resistant |
| ENSG00000258136.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.037840935 |
Resistant |
| ENSG00000258325.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.046301234 |
Resistant |
| ENSG00000258443.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.003759891 |
Resistant |
| ENSG00000258458.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.040485013 |
Resistant |
| ENSG00000258545.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.042388237 |
Resistant |
| ENSG00000258556.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.030165107 |
Resistant |
| ENSG00000258623.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.01748866 |
Resistant |
| ENSG00000258766.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.03361087 |
Resistant |
| ENSG00000258809.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.022762505 |
Resistant |
| ENSG00000259242.2 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.027389326 |
Resistant |
| ENSG00000259327.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.047233333 |
Resistant |
| ENSG00000259362.2 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.009960638 |
Resistant |
| ENSG00000259474.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.042142389 |
Resistant |
| ENSG00000259520.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.029045382 |
Resistant |
| ENSG00000259551.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.031495313 |
Resistant |
| ENSG00000259595.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.017388126 |
Resistant |
| ENSG00000259705.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.033111534 |
Resistant |
| ENSG00000259876.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.025590123 |
Resistant |
| ENSG00000259899.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.019158179 |
Resistant |
| ENSG00000260177.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.014361899 |
Resistant |
| ENSG00000260276.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.014653267 |
Resistant |
| ENSG00000260285.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.013696951 |
Resistant |
| ENSG00000260349.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.022135853 |
Resistant |
| ENSG00000260464.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.013859897 |
Resistant |
| ENSG00000260493.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.033531934 |
Resistant |
| ENSG00000260545.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.022333409 |
Resistant |
| ENSG00000260616.2 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.040994374 |
Resistant |
| ENSG00000260618.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.020078611 |
Resistant |
| ENSG00000260635.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.01699402 |
Resistant |
| ENSG00000260805.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.018491265 |
Resistant |
| ENSG00000260948.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.014480442 |
Resistant |
| ENSG00000260988.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.009639837 |
Resistant |
| ENSG00000261030.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.024301096 |
Resistant |
| ENSG00000261114.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.049276473 |
Resistant |
| ENSG00000261188.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.027113041 |
Resistant |
| ENSG00000261207.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.014084083 |
Resistant |
| ENSG00000261270.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.047351388 |
Resistant |
| ENSG00000261291.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.008910019 |
Resistant |
| ENSG00000261474.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.020281206 |
Resistant |
| ENSG00000261529.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.006387147 |
Resistant |
| ENSG00000261692.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.016791086 |
Resistant |
| ENSG00000261716.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.025269294 |
Resistant |
| ENSG00000262188.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.03034454 |
Resistant |
| ENSG00000262380.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.009515279 |
Resistant |
| ENSG00000262721.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.047010726 |
Resistant |
| ENSG00000262903.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.023966635 |
Resistant |
| ENSG00000262905.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.035196947 |
Resistant |
| ENSG00000262944.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.017432503 |
Resistant |
| ENSG00000263220.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.017857525 |
Resistant |
| ENSG00000263257.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.047087232 |
Resistant |
| ENSG00000263370.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.045388506 |
Resistant |
| ENSG00000263627.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.046221479 |
Resistant |
| ENSG00000263727.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.027669848 |
Resistant |
| ENSG00000263847.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.013739424 |
Resistant |
| ENSG00000265185.2 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.026715931 |
Resistant |
| ENSG00000266456.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.030321121 |
Resistant |
| ENSG00000267009.2 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.001812376 |
Resistant |
| ENSG00000267015.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.003783418 |
Resistant |
| ENSG00000267016.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.042691387 |
Resistant |
| ENSG00000267138.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.01335769 |
Resistant |
| ENSG00000267273.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.047287441 |
Resistant |
| ENSG00000267278.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.036412656 |
Resistant |
| ENSG00000267288.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.032327412 |
Resistant |
| ENSG00000267537.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.045031311 |
Resistant |
| ENSG00000267560.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.012054492 |
Resistant |
| ENSG00000267709.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.012784199 |
Resistant |
| ENSG00000268471.3 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.046537611 |
Resistant |
| ENSG00000269202.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.017915162 |
Resistant |
| ENSG00000269481.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.042433636 |
Resistant |
| ENSG00000270105.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.026070509 |
Resistant |
| ENSG00000270462.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.0344483 |
Resistant |
| ENSG00000270589.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.000343813 |
Resistant |
| ENSG00000270751.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.047769564 |
Resistant |
| ENSG00000271218.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.037153791 |
Resistant |
| ENSG00000271755.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.035344021 |
Resistant |
| ENSG00000271821.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.03297221 |
Resistant |
| ENSG00000271856.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.031294271 |
Resistant |
| ENSG00000272072.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.0250975 |
Resistant |
| ENSG00000272158.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.006912149 |
Resistant |
| ENSG00000272346.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.031135766 |
Resistant |
| ENSG00000272895.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.000833508 |
Resistant |
| ENSG00000272917.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.043336765 |
Resistant |
| ENSG00000272993.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.035902049 |
Resistant |
| ENSG00000273076.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.00237374 |
Resistant |
| ENSG00000176728.3 |
PF-562271 |
Brain lower grade glioma |
0.042806031 |
Resistant |
| ENSG00000227906.3 |
PF-562271 |
Brain lower grade glioma |
0.027098582 |
Resistant |
| ENSG00000230679.1 |
PF-562271 |
Brain lower grade glioma |
0.039674347 |
Resistant |
| ENSG00000232564.1 |
PF-562271 |
Brain lower grade glioma |
0.01863053 |
Resistant |
| ENSG00000232878.1 |
PF-562271 |
Brain lower grade glioma |
0.009504602 |
Resistant |
| ENSG00000234997.1 |
PF-562271 |
Brain lower grade glioma |
0.02463895 |
Resistant |
| ENSG00000235066.4 |
PF-562271 |
Brain lower grade glioma |
0.020848647 |
Resistant |
| ENSG00000235593.1 |
PF-562271 |
Brain lower grade glioma |
0.009690044 |
Resistant |
| ENSG00000236494.1 |
PF-562271 |
Brain lower grade glioma |
0.031117727 |
Resistant |
| ENSG00000237927.1 |
PF-562271 |
Brain lower grade glioma |
0.022751049 |
Resistant |
| ENSG00000239653.1 |
PF-562271 |
Brain lower grade glioma |
0.037570227 |
Resistant |
| ENSG00000241884.2 |
PF-562271 |
Brain lower grade glioma |
0.022058091 |
Resistant |
| ENSG00000247925.2 |
PF-562271 |
Brain lower grade glioma |
0.026843028 |
Resistant |
| ENSG00000248890.1 |
PF-562271 |
Brain lower grade glioma |
0.046906022 |
Resistant |
| ENSG00000249664.1 |
PF-562271 |
Brain lower grade glioma |
0.025046443 |
Resistant |
| ENSG00000250081.1 |
PF-562271 |
Brain lower grade glioma |
0.033876878 |
Resistant |
| ENSG00000254180.1 |
PF-562271 |
Brain lower grade glioma |
0.026439934 |
Resistant |
| ENSG00000254428.1 |
PF-562271 |
Brain lower grade glioma |
0.016588016 |
Resistant |
| ENSG00000254461.1 |
PF-562271 |
Brain lower grade glioma |
0.049220155 |
Resistant |
| ENSG00000255487.1 |
PF-562271 |
Brain lower grade glioma |
0.02940643 |
Resistant |
| ENSG00000255886.1 |
PF-562271 |
Brain lower grade glioma |
0.048530527 |
Resistant |
| ENSG00000255893.1 |
PF-562271 |
Brain lower grade glioma |
0.045438707 |
Resistant |
| ENSG00000256603.1 |
PF-562271 |
Brain lower grade glioma |
0.038204056 |
Resistant |
| ENSG00000257711.1 |
PF-562271 |
Brain lower grade glioma |
0.033091032 |
Resistant |
| ENSG00000258302.1 |
PF-562271 |
Brain lower grade glioma |
0.034234043 |
Resistant |
| ENSG00000258922.1 |
PF-562271 |
Brain lower grade glioma |
0.037292627 |
Resistant |
| ENSG00000259818.1 |
PF-562271 |
Brain lower grade glioma |
0.022864898 |
Resistant |
| ENSG00000260436.1 |
PF-562271 |
Brain lower grade glioma |
0.032588748 |
Resistant |
| ENSG00000262319.1 |
PF-562271 |
Brain lower grade glioma |
0.047224866 |
Resistant |
| ENSG00000263934.2 |
PF-562271 |
Brain lower grade glioma |
0.039472835 |
Resistant |
| ENSG00000265008.1 |
PF-562271 |
Brain lower grade glioma |
0.04961499 |
Resistant |
| ENSG00000265496.2 |
PF-562271 |
Brain lower grade glioma |
0.024799825 |
Resistant |
| ENSG00000266677.1 |
PF-562271 |
Brain lower grade glioma |
0.033156663 |
Resistant |
| ENSG00000267118.1 |
PF-562271 |
Brain lower grade glioma |
0.047292841 |
Resistant |
| ENSG00000267147.1 |
PF-562271 |
Brain lower grade glioma |
0.027801143 |
Resistant |
| ENSG00000267298.1 |
PF-562271 |
Brain lower grade glioma |
0.039708299 |
Resistant |
| ENSG00000267491.1 |
PF-562271 |
Brain lower grade glioma |
0.028581468 |
Resistant |
| ENSG00000268458.1 |
PF-562271 |
Brain lower grade glioma |
0.038793491 |
Resistant |
| ENSG00000269194.1 |
PF-562271 |
Brain lower grade glioma |
0.037712628 |
Resistant |
| ENSG00000178947.8 |
PF-562271 |
Lung squamous cell carcinoma |
0.011164587 |
Resistant |
| ENSG00000180769.4 |
PF-562271 |
Lung squamous cell carcinoma |
0.011944757 |
Resistant |
| ENSG00000196421.3 |
PF-562271 |
Lung squamous cell carcinoma |
0.047809658 |
Resistant |
| ENSG00000203605.3 |
PF-562271 |
Lung squamous cell carcinoma |
0.03404491 |
Resistant |
| ENSG00000214105.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.044815351 |
Resistant |
| ENSG00000216863.5 |
PF-562271 |
Lung squamous cell carcinoma |
0.027460769 |
Resistant |
| ENSG00000223652.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.036219123 |
Resistant |
| ENSG00000223834.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.030574764 |
Resistant |
| ENSG00000224713.3 |
PF-562271 |
Lung squamous cell carcinoma |
0.032812585 |
Resistant |
| ENSG00000224995.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.008698347 |
Resistant |
| ENSG00000225465.6 |
PF-562271 |
Lung squamous cell carcinoma |
0.028244536 |
Resistant |
| ENSG00000226087.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.021104165 |
Resistant |
| ENSG00000226377.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.043800693 |
Resistant |
| ENSG00000226571.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.016718555 |
Resistant |
| ENSG00000226627.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.040481014 |
Resistant |
| ENSG00000226954.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.023989873 |
Resistant |
| ENSG00000227091.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.029149491 |
Resistant |
| ENSG00000227128.3 |
PF-562271 |
Lung squamous cell carcinoma |
0.03888271 |
Resistant |
| ENSG00000227248.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.037171141 |
Resistant |
| ENSG00000227285.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.030969859 |
Resistant |
| ENSG00000228487.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.029556176 |
Resistant |
| ENSG00000229154.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.045310708 |
Resistant |
| ENSG00000229294.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.04257167 |
Resistant |
| ENSG00000229536.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.038779739 |
Resistant |
| ENSG00000229766.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.040633511 |
Resistant |
| ENSG00000230394.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.029152228 |
Resistant |
| ENSG00000230542.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.038426063 |
Resistant |
| ENSG00000230939.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.041229244 |
Resistant |
| ENSG00000231057.3 |
PF-562271 |
Lung squamous cell carcinoma |
0.042497683 |
Resistant |
| ENSG00000232018.4 |
PF-562271 |
Lung squamous cell carcinoma |
0.036320195 |
Resistant |
| ENSG00000232363.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.047511528 |
Resistant |
| ENSG00000232732.5 |
PF-562271 |
Lung squamous cell carcinoma |
0.032807926 |
Resistant |
| ENSG00000234084.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.004116545 |
Resistant |
| ENSG00000234206.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.021835507 |
Resistant |
| ENSG00000234252.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.032045507 |
Resistant |
| ENSG00000234445.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.035617016 |
Resistant |
| ENSG00000234848.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.03182014 |
Resistant |
| ENSG00000234921.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.039520942 |
Resistant |
| ENSG00000235526.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.040244606 |
Resistant |
| ENSG00000236545.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.006461108 |
Resistant |
| ENSG00000237027.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.033428349 |
Resistant |
| ENSG00000237234.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.048207641 |
Resistant |
| ENSG00000237438.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.022100682 |
Resistant |
| ENSG00000237457.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.029029734 |
Resistant |
| ENSG00000237742.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.042116941 |
Resistant |
| ENSG00000237750.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.035673259 |
Resistant |
| ENSG00000239664.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.021256999 |
Resistant |
| ENSG00000239994.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.049849653 |
Resistant |
| ENSG00000240401.4 |
PF-562271 |
Lung squamous cell carcinoma |
0.033387917 |
Resistant |
| ENSG00000241054.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.04321008 |
Resistant |
| ENSG00000241505.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.017467405 |
Resistant |
| ENSG00000243319.3 |
PF-562271 |
Lung squamous cell carcinoma |
0.041484495 |
Resistant |
| ENSG00000243485.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.009794191 |
Resistant |
| ENSG00000243533.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.04242822 |
Resistant |
| ENSG00000243715.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.032643007 |
Resistant |
| ENSG00000244215.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.025653096 |
Resistant |
| ENSG00000246379.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.042210183 |
Resistant |
| ENSG00000246851.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.035432442 |
Resistant |
| ENSG00000247363.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.046907573 |
Resistant |
| ENSG00000248206.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.046179086 |
Resistant |
| ENSG00000248416.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.03782538 |
Resistant |
| ENSG00000248664.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.015640917 |
Resistant |
| ENSG00000249258.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.019144613 |
Resistant |
| ENSG00000249664.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.043707773 |
Resistant |
| ENSG00000250802.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.035979787 |
Resistant |
| ENSG00000251497.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.026081806 |
Resistant |
| ENSG00000253477.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.044274724 |
Resistant |
| ENSG00000253576.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.036984928 |
Resistant |
| ENSG00000254347.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.018597879 |
Resistant |
| ENSG00000254615.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.039667177 |
Resistant |
| ENSG00000254689.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.038211309 |
Resistant |
| ENSG00000255118.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.022219303 |
Resistant |
| ENSG00000255428.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.040931251 |
Resistant |
| ENSG00000256031.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.01941527 |
Resistant |
| ENSG00000257056.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.021496902 |
Resistant |
| ENSG00000257095.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.016992536 |
Resistant |
| ENSG00000257126.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.015573608 |
Resistant |
| ENSG00000257568.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.046270771 |
Resistant |
| ENSG00000257613.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.042637605 |
Resistant |
| ENSG00000257748.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.038149342 |
Resistant |
| ENSG00000258119.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.046326858 |
Resistant |
| ENSG00000258592.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.037751077 |
Resistant |
| ENSG00000259002.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.009239151 |
Resistant |
| ENSG00000259055.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.027879061 |
Resistant |
| ENSG00000259296.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.039525982 |
Resistant |
| ENSG00000259376.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.041951249 |
Resistant |
| ENSG00000259843.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.023048141 |
Resistant |
| ENSG00000259954.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.026078723 |
Resistant |
| ENSG00000260185.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.045543512 |
Resistant |
| ENSG00000260296.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.040620909 |
Resistant |
| ENSG00000260331.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.023913178 |
Resistant |
| ENSG00000260381.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.035388453 |
Resistant |
| ENSG00000260440.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.023012948 |
Resistant |
| ENSG00000260614.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.027765128 |
Resistant |
| ENSG00000260855.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.038978714 |
Resistant |
| ENSG00000261185.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.038051221 |
Resistant |
| ENSG00000261384.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.026998098 |
Resistant |
| ENSG00000261416.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.019316549 |
Resistant |
| ENSG00000261695.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.010573991 |
Resistant |
| ENSG00000262810.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.029911181 |
Resistant |
| ENSG00000263924.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.01289676 |
Resistant |
| ENSG00000263938.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.037590933 |
Resistant |
| ENSG00000264365.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.008608956 |
Resistant |
| ENSG00000265094.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.04451533 |
Resistant |
| ENSG00000265204.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.041394442 |
Resistant |
| ENSG00000266290.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.013607886 |
Resistant |
| ENSG00000266573.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.037214755 |
Resistant |
| ENSG00000266599.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.042434696 |
Resistant |
| ENSG00000266667.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.047035961 |
Resistant |
| ENSG00000266913.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.030594957 |
Resistant |
| ENSG00000266935.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.048739401 |
Resistant |
| ENSG00000267161.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.049704881 |
Resistant |
| ENSG00000267251.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.035309887 |
Resistant |
| ENSG00000267273.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.036816247 |
Resistant |
| ENSG00000267373.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.022462043 |
Resistant |
| ENSG00000267381.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.033876024 |
Resistant |
| ENSG00000267424.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.046381002 |
Resistant |
| ENSG00000267642.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.043014562 |
Resistant |
| ENSG00000267655.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.022207989 |
Resistant |
| ENSG00000268051.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.042506016 |
Resistant |
| ENSG00000269694.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.04389671 |
Resistant |
| ENSG00000269752.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.038193871 |
Resistant |
| ENSG00000269973.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.024777332 |
Resistant |
| ENSG00000270996.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.017576395 |
Resistant |
| ENSG00000271417.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.043503945 |
Resistant |
| ENSG00000271732.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.03444794 |
Resistant |
| ENSG00000271757.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.0378432 |
Resistant |
| ENSG00000271833.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.03119182 |
Resistant |
| ENSG00000272452.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.018803304 |
Resistant |
| ENSG00000272516.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.046731171 |
Resistant |
| ENSG00000272562.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.017564493 |
Resistant |
| ENSG00000272717.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.018695552 |
Resistant |
| ENSG00000272931.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.003965411 |
Resistant |
| ENSG00000272977.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.042601051 |
Resistant |
| ENSG00000273030.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.02392956 |
Resistant |
| ENSG00000273203.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.018746069 |
Resistant |
| ENSG00000273442.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.044418777 |
Resistant |
| ENSG00000145063.10 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.000541864 |
Resistant |
| ENSG00000178193.5 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.01751993 |
Resistant |
| ENSG00000178412.4 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.03281383 |
Resistant |
| ENSG00000203650.3 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.005765357 |
Resistant |
| ENSG00000204802.3 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.033609499 |
Resistant |
| ENSG00000206176.5 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.000971019 |
Resistant |
| ENSG00000214725.3 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.020581623 |
Resistant |
| ENSG00000220161.4 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.03736259 |
Resistant |
| ENSG00000223855.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.043247101 |
Resistant |
| ENSG00000224945.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.000533513 |
Resistant |
| ENSG00000225096.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.014280129 |
Resistant |
| ENSG00000225914.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.049735626 |
Resistant |
| ENSG00000225964.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.046966074 |
Resistant |
| ENSG00000226009.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.001418812 |
Resistant |
| ENSG00000226377.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.000738516 |
Resistant |
| ENSG00000226465.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.025521765 |
Resistant |
| ENSG00000226969.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.003461753 |
Resistant |
| ENSG00000227252.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.040372096 |
Resistant |
| ENSG00000227888.3 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.004906509 |
Resistant |
| ENSG00000228192.3 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.037293902 |
Resistant |
| ENSG00000228204.2 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.0000512 |
Resistant |
| ENSG00000228988.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.013766794 |
Resistant |
| ENSG00000229356.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.038422143 |
Resistant |
| ENSG00000229521.2 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.018526705 |
Resistant |
| ENSG00000229869.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.021903128 |
Resistant |
| ENSG00000229915.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.002664529 |
Resistant |
| ENSG00000230914.2 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.030799857 |
Resistant |
| ENSG00000232233.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.0131877 |
Resistant |
| ENSG00000232363.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.045200641 |
Resistant |
| ENSG00000232527.3 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.007670936 |
Resistant |
| ENSG00000233008.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.000373816 |
Resistant |
| ENSG00000233029.3 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.014838042 |
Resistant |
| ENSG00000233223.2 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.012813572 |
Resistant |
| ENSG00000234571.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.019496739 |
Resistant |
| ENSG00000235007.2 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.02152919 |
Resistant |
| ENSG00000235010.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.028756857 |
Resistant |
| ENSG00000236008.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.022207785 |
Resistant |
| ENSG00000236345.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.041170101 |
Resistant |
| ENSG00000236526.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.00315353 |
Resistant |
| ENSG00000236540.3 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.039588466 |
Resistant |
| ENSG00000237357.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.001258923 |
Resistant |
| ENSG00000238266.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.042645197 |
Resistant |
| ENSG00000240859.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.000232272 |
Resistant |
| ENSG00000241155.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.030730953 |
Resistant |
| ENSG00000241732.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.003132753 |
Resistant |
| ENSG00000242767.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.034695063 |
Resistant |
| ENSG00000242973.2 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.008768236 |
Resistant |
| ENSG00000244332.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.001410856 |
Resistant |
| ENSG00000244459.2 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.018571498 |
Resistant |
| ENSG00000245857.2 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.006203397 |
Resistant |
| ENSG00000246898.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.008138092 |
Resistant |
| ENSG00000247853.2 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.000236746 |
Resistant |
| ENSG00000248243.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.004696157 |
Resistant |
| ENSG00000249509.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.015504496 |
Resistant |
| ENSG00000249849.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.037375716 |
Resistant |
| ENSG00000251532.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.009954365 |
Resistant |
| ENSG00000253301.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.01355795 |
Resistant |
| ENSG00000253477.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.000606764 |
Resistant |
| ENSG00000253653.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.024409969 |
Resistant |
| ENSG00000253678.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.041548005 |
Resistant |
| ENSG00000254444.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.003365177 |
Resistant |
| ENSG00000254574.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.044773201 |
Resistant |
| ENSG00000255234.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.041415765 |
Resistant |
| ENSG00000255236.2 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.042249255 |
Resistant |
| ENSG00000256670.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.047372536 |
Resistant |
| ENSG00000256742.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.035604382 |
Resistant |
| ENSG00000256746.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.000165685 |
Resistant |
| ENSG00000257027.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.032672296 |
Resistant |
| ENSG00000257910.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.020785836 |
Resistant |
| ENSG00000258811.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016355314 |
Resistant |
| ENSG00000258959.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.004953352 |
Resistant |
| ENSG00000259182.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.042950898 |
Resistant |
| ENSG00000259343.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.007859643 |
Resistant |
| ENSG00000259888.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.029341568 |
Resistant |
| ENSG00000259935.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.006488705 |
Resistant |
| ENSG00000260281.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.041171457 |
Resistant |
| ENSG00000261437.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.008520569 |
Resistant |
| ENSG00000261572.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.020653671 |
Resistant |
| ENSG00000261804.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.008901996 |
Resistant |
| ENSG00000262147.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.030108692 |
Resistant |
| ENSG00000263400.2 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.006276677 |
Resistant |
| ENSG00000263893.2 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.000874142 |
Resistant |
| ENSG00000264575.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016370444 |
Resistant |
| ENSG00000264954.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.002006064 |
Resistant |
| ENSG00000265091.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.017177833 |
Resistant |
| ENSG00000266256.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.013785378 |
Resistant |
| ENSG00000266312.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.032371869 |
Resistant |
| ENSG00000266783.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.017882654 |
Resistant |
| ENSG00000267302.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.009291751 |
Resistant |
| ENSG00000267390.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.013926013 |
Resistant |
| ENSG00000267715.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.040412311 |
Resistant |
| ENSG00000268307.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.015896123 |
Resistant |
| ENSG00000268621.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.00062293 |
Resistant |
| ENSG00000268751.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.031178885 |
Resistant |
| ENSG00000269688.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.002948078 |
Resistant |
| ENSG00000270074.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.01990687 |
Resistant |
| ENSG00000270127.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.006320537 |
Resistant |
| ENSG00000270246.2 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.008103566 |
Resistant |
| ENSG00000270344.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.001849437 |
Resistant |
| ENSG00000270742.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.040220799 |
Resistant |
| ENSG00000271782.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.000447526 |
Resistant |
| ENSG00000272209.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.007769031 |
Resistant |
| ENSG00000272512.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.017081984 |
Resistant |
| ENSG00000272760.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.015723236 |
Resistant |
| ENSG00000272764.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.006233302 |
Resistant |
| ENSG00000272787.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.034118701 |
Resistant |
| ENSG00000272859.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.027827017 |
Resistant |
| ENSG00000272922.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.023206415 |
Resistant |
| ENSG00000100181.17 |
PF-562271 |
Pancreatic adenocarcinoma |
0.02758219 |
Resistant |
| ENSG00000124915.6 |
PF-562271 |
Pancreatic adenocarcinoma |
0.004192785 |
Resistant |
| ENSG00000126005.11 |
PF-562271 |
Pancreatic adenocarcinoma |
0.035760247 |
Resistant |
| ENSG00000170161.6 |
PF-562271 |
Pancreatic adenocarcinoma |
0.030976856 |
Resistant |
| ENSG00000189223.9 |
PF-562271 |
Pancreatic adenocarcinoma |
0.038199717 |
Resistant |
| ENSG00000197085.7 |
PF-562271 |
Pancreatic adenocarcinoma |
0.01752113 |
Resistant |
| ENSG00000203497.2 |
PF-562271 |
Pancreatic adenocarcinoma |
0.004787975 |
Resistant |
| ENSG00000213742.2 |
PF-562271 |
Pancreatic adenocarcinoma |
0.014265135 |
Resistant |
| ENSG00000214955.5 |
PF-562271 |
Pancreatic adenocarcinoma |
0.035487171 |
Resistant |
| ENSG00000223571.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.038315554 |
Resistant |
| ENSG00000223797.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.013374507 |
Resistant |
| ENSG00000224638.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.011583297 |
Resistant |
| ENSG00000225187.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.038835164 |
Resistant |
| ENSG00000225331.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.029138857 |
Resistant |
| ENSG00000226649.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.009502037 |
Resistant |
| ENSG00000226754.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.017866965 |
Resistant |
| ENSG00000227014.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.035763142 |
Resistant |
| ENSG00000227053.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.017990532 |
Resistant |
| ENSG00000227373.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.014171552 |
Resistant |
| ENSG00000227479.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.017030246 |
Resistant |
| ENSG00000227502.2 |
PF-562271 |
Pancreatic adenocarcinoma |
0.009572363 |
Resistant |
| ENSG00000228043.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.041125102 |
Resistant |
| ENSG00000228323.2 |
PF-562271 |
Pancreatic adenocarcinoma |
0.003837639 |
Resistant |
| ENSG00000228389.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.022748592 |
Resistant |
| ENSG00000228506.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.041599154 |
Resistant |
| ENSG00000228554.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.03355414 |
Resistant |
| ENSG00000228677.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.020259765 |
Resistant |
| ENSG00000228886.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.014498944 |
Resistant |
| ENSG00000230010.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.044624713 |
Resistant |
| ENSG00000231226.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.012272667 |
Resistant |
| ENSG00000231651.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.018001061 |
Resistant |
| ENSG00000232442.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.028604482 |
Resistant |
| ENSG00000232712.2 |
PF-562271 |
Pancreatic adenocarcinoma |
0.010773628 |
Resistant |
| ENSG00000232912.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.019166728 |
Resistant |
| ENSG00000232913.3 |
PF-562271 |
Pancreatic adenocarcinoma |
0.001916361 |
Resistant |
| ENSG00000234072.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.015439142 |
Resistant |
| ENSG00000234171.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.04545171 |
Resistant |
| ENSG00000234678.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.011268909 |
Resistant |
| ENSG00000235399.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.047600706 |
Resistant |
| ENSG00000235481.2 |
PF-562271 |
Pancreatic adenocarcinoma |
0.046024545 |
Resistant |
| ENSG00000236388.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.006908612 |
Resistant |
| ENSG00000236434.2 |
PF-562271 |
Pancreatic adenocarcinoma |
0.049027542 |
Resistant |
| ENSG00000236559.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.016715979 |
Resistant |
| ENSG00000236643.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.024793069 |
Resistant |
| ENSG00000237520.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.000456885 |
Resistant |
| ENSG00000237596.2 |
PF-562271 |
Pancreatic adenocarcinoma |
0.015655935 |
Resistant |
| ENSG00000237697.2 |
PF-562271 |
Pancreatic adenocarcinoma |
0.002196661 |
Resistant |
| ENSG00000238005.2 |
PF-562271 |
Pancreatic adenocarcinoma |
0.011680533 |
Resistant |
| ENSG00000238140.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.009964865 |
Resistant |
| ENSG00000238164.2 |
PF-562271 |
Pancreatic adenocarcinoma |
0.025556827 |
Resistant |
| ENSG00000239508.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.014431708 |
Resistant |
| ENSG00000239930.2 |
PF-562271 |
Pancreatic adenocarcinoma |
0.039458252 |
Resistant |
| ENSG00000242908.2 |
PF-562271 |
Pancreatic adenocarcinoma |
0.013820393 |
Resistant |
| ENSG00000245148.2 |
PF-562271 |
Pancreatic adenocarcinoma |
0.001485996 |
Resistant |
| ENSG00000246363.2 |
PF-562271 |
Pancreatic adenocarcinoma |
0.012803209 |
Resistant |
| ENSG00000247381.2 |
PF-562271 |
Pancreatic adenocarcinoma |
0.008535438 |
Resistant |
| ENSG00000248559.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.011082377 |
Resistant |
| ENSG00000248925.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.009529693 |
Resistant |
| ENSG00000249407.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.009599149 |
Resistant |
| ENSG00000250057.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.0474019 |
Resistant |
| ENSG00000250410.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.034390986 |
Resistant |
| ENSG00000250451.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.025412745 |
Resistant |
| ENSG00000251417.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.00984297 |
Resistant |
| ENSG00000251442.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.039102265 |
Resistant |
| ENSG00000253666.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.016291577 |
Resistant |
| ENSG00000253669.3 |
PF-562271 |
Pancreatic adenocarcinoma |
0.022248274 |
Resistant |
| ENSG00000253696.2 |
PF-562271 |
Pancreatic adenocarcinoma |
0.009079468 |
Resistant |
| ENSG00000254109.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.034752844 |
Resistant |
| ENSG00000255237.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.000879468 |
Resistant |
| ENSG00000255741.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.049260181 |
Resistant |
| ENSG00000256092.2 |
PF-562271 |
Pancreatic adenocarcinoma |
0.010136623 |
Resistant |
| ENSG00000256325.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.0474057 |
Resistant |
| ENSG00000256542.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.018010219 |
Resistant |
| ENSG00000256943.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.027248717 |
Resistant |
| ENSG00000257283.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.002188126 |
Resistant |
| ENSG00000257475.2 |
PF-562271 |
Pancreatic adenocarcinoma |
0.007686131 |
Resistant |
| ENSG00000258001.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.006297769 |
Resistant |
| ENSG00000258620.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.035725005 |
Resistant |
| ENSG00000259001.2 |
PF-562271 |
Pancreatic adenocarcinoma |
0.003433238 |
Resistant |
| ENSG00000259294.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.048671886 |
Resistant |
| ENSG00000259915.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.016257071 |
Resistant |
| ENSG00000260118.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.00109981 |
Resistant |
| ENSG00000260136.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.002116545 |
Resistant |
| ENSG00000260209.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.025606493 |
Resistant |
| ENSG00000260261.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.035095939 |
Resistant |
| ENSG00000260273.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.036007314 |
Resistant |
| ENSG00000260329.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.017389488 |
Resistant |
| ENSG00000260657.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.016606122 |
Resistant |
| ENSG00000260698.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.045743359 |
Resistant |
| ENSG00000260735.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.025571619 |
Resistant |
| ENSG00000260891.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.020150285 |
Resistant |
| ENSG00000261140.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.011186581 |
Resistant |
| ENSG00000261170.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.02319729 |
Resistant |
| ENSG00000261291.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.001176531 |
Resistant |
| ENSG00000261451.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.047806126 |
Resistant |
| ENSG00000261468.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.046135032 |
Resistant |
| ENSG00000261592.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.012494738 |
Resistant |
| ENSG00000262468.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.004650029 |
Resistant |
| ENSG00000262558.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.020553598 |
Resistant |
| ENSG00000263105.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.029235195 |
Resistant |
| ENSG00000265728.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.01884309 |
Resistant |
| ENSG00000265984.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.011604444 |
Resistant |
| ENSG00000266969.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.028979813 |
Resistant |
| ENSG00000266994.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.020136438 |
Resistant |
| ENSG00000267009.2 |
PF-562271 |
Pancreatic adenocarcinoma |
0.033691847 |
Resistant |
| ENSG00000267905.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.008096891 |
Resistant |
| ENSG00000268520.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.007253008 |
Resistant |
| ENSG00000269444.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.019259435 |
Resistant |
| ENSG00000269887.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.012817373 |
Resistant |
| ENSG00000270001.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.026300784 |
Resistant |
| ENSG00000270130.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.037407508 |
Resistant |
| ENSG00000271119.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.010442447 |
Resistant |
| ENSG00000271398.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.005243269 |
Resistant |
| ENSG00000271833.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.049895495 |
Resistant |
| ENSG00000272250.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.010182686 |
Resistant |
| ENSG00000272473.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.008035523 |
Resistant |
| ENSG00000272498.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.04974136 |
Resistant |
| ENSG00000272669.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.02877962 |
Resistant |
| ENSG00000273290.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.001223184 |
Resistant |
| ENSG00000273407.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.03982696 |
Resistant |
| ENSG00000170161.6 |
PF-562271 |
Sarcoma |
0.024908654 |
Resistant |
| ENSG00000204362.5 |
PF-562271 |
Sarcoma |
0.00259218 |
Resistant |
| ENSG00000223734.2 |
PF-562271 |
Sarcoma |
0.043118853 |
Resistant |
| ENSG00000223779.4 |
PF-562271 |
Sarcoma |
0.025361275 |
Resistant |
| ENSG00000223791.1 |
PF-562271 |
Sarcoma |
0.027863311 |
Resistant |
| ENSG00000223842.1 |
PF-562271 |
Sarcoma |
0.021825136 |
Resistant |
| ENSG00000224577.1 |
PF-562271 |
Sarcoma |
0.029988142 |
Resistant |
| ENSG00000225163.3 |
PF-562271 |
Sarcoma |
0.046507274 |
Resistant |
| ENSG00000225265.1 |
PF-562271 |
Sarcoma |
0.003095083 |
Resistant |
| ENSG00000227540.1 |
PF-562271 |
Sarcoma |
0.005919458 |
Resistant |
| ENSG00000228775.3 |
PF-562271 |
Sarcoma |
0.043563888 |
Resistant |
| ENSG00000229404.1 |
PF-562271 |
Sarcoma |
0.002855645 |
Resistant |
| ENSG00000231028.4 |
PF-562271 |
Sarcoma |
0.005382465 |
Resistant |
| ENSG00000231595.1 |
PF-562271 |
Sarcoma |
0.01319891 |
Resistant |
| ENSG00000232284.3 |
PF-562271 |
Sarcoma |
0.016861102 |
Resistant |
| ENSG00000232342.3 |
PF-562271 |
Sarcoma |
0.029804974 |
Resistant |
| ENSG00000232613.2 |
PF-562271 |
Sarcoma |
0.035947091 |
Resistant |
| ENSG00000234264.1 |
PF-562271 |
Sarcoma |
0.044163663 |
Resistant |
| ENSG00000234584.1 |
PF-562271 |
Sarcoma |
0.020699037 |
Resistant |
| ENSG00000235843.1 |
PF-562271 |
Sarcoma |
0.034175216 |
Resistant |
| ENSG00000237021.2 |
PF-562271 |
Sarcoma |
0.004314259 |
Resistant |
| ENSG00000240050.1 |
PF-562271 |
Sarcoma |
0.025994231 |
Resistant |
| ENSG00000240207.2 |
PF-562271 |
Sarcoma |
0.038721976 |
Resistant |
| ENSG00000242622.1 |
PF-562271 |
Sarcoma |
0.013972994 |
Resistant |
| ENSG00000244286.1 |
PF-562271 |
Sarcoma |
0.038131418 |
Resistant |
| ENSG00000245060.2 |
PF-562271 |
Sarcoma |
0.022495669 |
Resistant |
| ENSG00000251018.2 |
PF-562271 |
Sarcoma |
0.046590389 |
Resistant |
| ENSG00000251497.2 |
PF-562271 |
Sarcoma |
0.026662401 |
Resistant |
| ENSG00000251513.1 |
PF-562271 |
Sarcoma |
0.03545351 |
Resistant |
| ENSG00000254444.1 |
PF-562271 |
Sarcoma |
0.040159959 |
Resistant |
| ENSG00000255276.1 |
PF-562271 |
Sarcoma |
0.020377618 |
Resistant |
| ENSG00000256381.1 |
PF-562271 |
Sarcoma |
0.033983307 |
Resistant |
| ENSG00000258458.1 |
PF-562271 |
Sarcoma |
0.035648789 |
Resistant |
| ENSG00000258479.1 |
PF-562271 |
Sarcoma |
0.008242053 |
Resistant |
| ENSG00000259376.1 |
PF-562271 |
Sarcoma |
0.023534662 |
Resistant |
| ENSG00000259760.1 |
PF-562271 |
Sarcoma |
0.017976427 |
Resistant |
| ENSG00000260167.1 |
PF-562271 |
Sarcoma |
0.038819382 |
Resistant |
| ENSG00000260277.1 |
PF-562271 |
Sarcoma |
0.033579895 |
Resistant |
| ENSG00000260572.1 |
PF-562271 |
Sarcoma |
0.012182392 |
Resistant |
| ENSG00000261366.1 |
PF-562271 |
Sarcoma |
0.006735918 |
Resistant |
| ENSG00000261777.1 |
PF-562271 |
Sarcoma |
0.021905096 |
Resistant |
| ENSG00000262172.1 |
PF-562271 |
Sarcoma |
0.010433796 |
Resistant |
| ENSG00000263624.1 |
PF-562271 |
Sarcoma |
0.015438927 |
Resistant |
| ENSG00000264860.1 |
PF-562271 |
Sarcoma |
0.025232638 |
Resistant |
| ENSG00000268362.1 |
PF-562271 |
Sarcoma |
0.029665841 |
Resistant |
| ENSG00000270419.1 |
PF-562271 |
Sarcoma |
0.031699297 |
Resistant |
| ENSG00000270828.1 |
PF-562271 |
Sarcoma |
0.029797626 |
Resistant |
| ENSG00000271382.1 |
PF-562271 |
Sarcoma |
0.00967144 |
Resistant |
| ENSG00000271821.1 |
PF-562271 |
Sarcoma |
0.009453972 |
Resistant |
| ENSG00000271993.1 |
PF-562271 |
Sarcoma |
0.039079622 |
Resistant |
| ENSG00000272070.1 |
PF-562271 |
Sarcoma |
0.046317401 |
Resistant |
| ENSG00000272403.1 |
PF-562271 |
Sarcoma |
0.017056686 |
Resistant |
| ENSG00000272444.1 |
PF-562271 |
Sarcoma |
0.036957646 |
Resistant |
| ENSG00000272966.1 |
PF-562271 |
Sarcoma |
0.022677879 |
Resistant |
| ENSG00000273381.1 |
PF-562271 |
Sarcoma |
0.047133826 |
Resistant |
| ENSG00000204832.5 |
PF-562271 |
Skin cutaneous melanoma |
0.046840359 |
Resistant |
| ENSG00000223392.1 |
PF-562271 |
Skin cutaneous melanoma |
0.02665708 |
Resistant |
| ENSG00000223401.1 |
PF-562271 |
Skin cutaneous melanoma |
0.02131494 |
Resistant |
| ENSG00000224885.1 |
PF-562271 |
Skin cutaneous melanoma |
0.016837011 |
Resistant |
| ENSG00000226380.3 |
PF-562271 |
Skin cutaneous melanoma |
0.038560532 |
Resistant |
| ENSG00000227911.3 |
PF-562271 |
Skin cutaneous melanoma |
0.044049819 |
Resistant |
| ENSG00000228412.2 |
PF-562271 |
Skin cutaneous melanoma |
0.045971064 |
Resistant |
| ENSG00000228686.2 |
PF-562271 |
Skin cutaneous melanoma |
0.039446862 |
Resistant |
| ENSG00000229739.1 |
PF-562271 |
Skin cutaneous melanoma |
0.030759 |
Resistant |
| ENSG00000229839.2 |
PF-562271 |
Skin cutaneous melanoma |
0.020567712 |
Resistant |
| ENSG00000230433.1 |
PF-562271 |
Skin cutaneous melanoma |
0.019770576 |
Resistant |
| ENSG00000230937.5 |
PF-562271 |
Skin cutaneous melanoma |
0.014400829 |
Resistant |
| ENSG00000231185.2 |
PF-562271 |
Skin cutaneous melanoma |
0.035778702 |
Resistant |
| ENSG00000231355.1 |
PF-562271 |
Skin cutaneous melanoma |
0.01738186 |
Resistant |
| ENSG00000232411.1 |
PF-562271 |
Skin cutaneous melanoma |
0.047051503 |
Resistant |
| ENSG00000232684.1 |
PF-562271 |
Skin cutaneous melanoma |
0.042039173 |
Resistant |
| ENSG00000234318.1 |
PF-562271 |
Skin cutaneous melanoma |
0.035479992 |
Resistant |
| ENSG00000235192.1 |
PF-562271 |
Skin cutaneous melanoma |
0.042325546 |
Resistant |
| ENSG00000235772.1 |
PF-562271 |
Skin cutaneous melanoma |
0.044889989 |
Resistant |
| ENSG00000237798.1 |
PF-562271 |
Skin cutaneous melanoma |
0.0431068 |
Resistant |
| ENSG00000238186.1 |
PF-562271 |
Skin cutaneous melanoma |
0.041250704 |
Resistant |
| ENSG00000246777.1 |
PF-562271 |
Skin cutaneous melanoma |
0.018940259 |
Resistant |
| ENSG00000253174.2 |
PF-562271 |
Skin cutaneous melanoma |
0.035956095 |
Resistant |
| ENSG00000253404.1 |
PF-562271 |
Skin cutaneous melanoma |
0.049407409 |
Resistant |
| ENSG00000253641.1 |
PF-562271 |
Skin cutaneous melanoma |
0.036859165 |
Resistant |
| ENSG00000254238.1 |
PF-562271 |
Skin cutaneous melanoma |
0.029303256 |
Resistant |
| ENSG00000254900.1 |
PF-562271 |
Skin cutaneous melanoma |
0.019455043 |
Resistant |
| ENSG00000255509.2 |
PF-562271 |
Skin cutaneous melanoma |
0.037015489 |
Resistant |
| ENSG00000258526.1 |
PF-562271 |
Skin cutaneous melanoma |
0.017635825 |
Resistant |
| ENSG00000258663.1 |
PF-562271 |
Skin cutaneous melanoma |
0.037257038 |
Resistant |
| ENSG00000259238.1 |
PF-562271 |
Skin cutaneous melanoma |
0.002577615 |
Resistant |
| ENSG00000260273.1 |
PF-562271 |
Skin cutaneous melanoma |
0.020175516 |
Resistant |
| ENSG00000260417.1 |
PF-562271 |
Skin cutaneous melanoma |
0.024784288 |
Resistant |
| ENSG00000260891.1 |
PF-562271 |
Skin cutaneous melanoma |
0.034804756 |
Resistant |
| ENSG00000261186.1 |
PF-562271 |
Skin cutaneous melanoma |
0.032766997 |
Resistant |
| ENSG00000261396.1 |
PF-562271 |
Skin cutaneous melanoma |
0.044301439 |
Resistant |
| ENSG00000261469.1 |
PF-562271 |
Skin cutaneous melanoma |
0.007808251 |
Resistant |
| ENSG00000261731.2 |
PF-562271 |
Skin cutaneous melanoma |
0.032592041 |
Resistant |
| ENSG00000264188.1 |
PF-562271 |
Skin cutaneous melanoma |
0.031110461 |
Resistant |
| ENSG00000266976.1 |
PF-562271 |
Skin cutaneous melanoma |
0.007928442 |
Resistant |
| ENSG00000267251.1 |
PF-562271 |
Skin cutaneous melanoma |
0.022136773 |
Resistant |
| ENSG00000267701.1 |
PF-562271 |
Skin cutaneous melanoma |
0.039230578 |
Resistant |
| ENSG00000267702.1 |
PF-562271 |
Skin cutaneous melanoma |
0.040606145 |
Resistant |
| ENSG00000267758.1 |
PF-562271 |
Skin cutaneous melanoma |
0.006233761 |
Resistant |
| ENSG00000270066.2 |
PF-562271 |
Skin cutaneous melanoma |
0.003441072 |
Resistant |
| ENSG00000271554.1 |
PF-562271 |
Skin cutaneous melanoma |
0.017461391 |
Resistant |
| ENSG00000271851.1 |
PF-562271 |
Skin cutaneous melanoma |
0.003751226 |
Resistant |
| ENSG00000272077.1 |
PF-562271 |
Skin cutaneous melanoma |
0.017498654 |
Resistant |
| ENSG00000272425.1 |
PF-562271 |
Skin cutaneous melanoma |
0.018281913 |
Resistant |
| ENSG00000272940.1 |
PF-562271 |
Skin cutaneous melanoma |
0.007789655 |
Resistant |
| ENSG00000273084.1 |
PF-562271 |
Skin cutaneous melanoma |
0.02571907 |
Resistant |
| ENSG00000224023.6 |
PF-562271 |
Thyroid carcinoma |
0.021428952 |
Resistant |
| ENSG00000227811.2 |
PF-562271 |
Thyroid carcinoma |
0.04607263 |
Resistant |
| ENSG00000228021.3 |
PF-562271 |
Thyroid carcinoma |
0.026332833 |
Resistant |
| ENSG00000228340.1 |
PF-562271 |
Thyroid carcinoma |
0.012889788 |
Resistant |
| ENSG00000231010.1 |
PF-562271 |
Thyroid carcinoma |
0.040217128 |
Resistant |
| ENSG00000231073.1 |
PF-562271 |
Thyroid carcinoma |
0.009861015 |
Resistant |
| ENSG00000233654.1 |
PF-562271 |
Thyroid carcinoma |
0.025093908 |
Resistant |
| ENSG00000234019.1 |
PF-562271 |
Thyroid carcinoma |
0.030620501 |
Resistant |
| ENSG00000234210.1 |
PF-562271 |
Thyroid carcinoma |
0.038394083 |
Resistant |
| ENSG00000240449.1 |
PF-562271 |
Thyroid carcinoma |
0.001230901 |
Resistant |
| ENSG00000257910.1 |
PF-562271 |
Thyroid carcinoma |
0.028214074 |
Resistant |
| ENSG00000258486.2 |
PF-562271 |
Thyroid carcinoma |
0.044350658 |
Resistant |
| ENSG00000259319.1 |
PF-562271 |
Thyroid carcinoma |
0.014472411 |
Resistant |
| ENSG00000259804.1 |
PF-562271 |
Thyroid carcinoma |
0.010362581 |
Resistant |
| ENSG00000263680.2 |
PF-562271 |
Thyroid carcinoma |
0.010697432 |
Resistant |
| ENSG00000265204.1 |
PF-562271 |
Thyroid carcinoma |
0.009178514 |
Resistant |
| ENSG00000267117.1 |
PF-562271 |
Thyroid carcinoma |
0.034088145 |
Resistant |
| ENSG00000267666.1 |
PF-562271 |
Thyroid carcinoma |
0.045635204 |
Resistant |
| ENSG00000268518.1 |
PF-562271 |
Thyroid carcinoma |
0.035451673 |
Resistant |
| ENSG00000269397.1 |
PF-562271 |
Thyroid carcinoma |
0.024931616 |
Resistant |
| ENSG00000271781.1 |
PF-562271 |
Thyroid carcinoma |
0.048659379 |
Resistant |
| ENSG00000272828.1 |
PF-562271 |
Thyroid carcinoma |
0.02794153 |
Resistant |
| ENSG00000203280.3 |
PF-562271 |
Bladder urothelial carcinoma |
0.031132146 |
Sensitive |
| ENSG00000223804.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.010699846 |
Sensitive |
| ENSG00000224623.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.015850978 |
Sensitive |
| ENSG00000224992.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.048889186 |
Sensitive |
| ENSG00000226179.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.03605284 |
Sensitive |
| ENSG00000226272.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.026657969 |
Sensitive |
| ENSG00000226465.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.042553679 |
Sensitive |
| ENSG00000228063.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.003007486 |
Sensitive |
| ENSG00000228686.2 |
PF-562271 |
Bladder urothelial carcinoma |
0.020834197 |
Sensitive |
| ENSG00000228791.3 |
PF-562271 |
Bladder urothelial carcinoma |
0.03559959 |
Sensitive |
| ENSG00000229780.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.020431342 |
Sensitive |
| ENSG00000230658.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.04461134 |
Sensitive |
| ENSG00000231551.2 |
PF-562271 |
Bladder urothelial carcinoma |
0.01139785 |
Sensitive |
| ENSG00000233368.2 |
PF-562271 |
Bladder urothelial carcinoma |
0.047482168 |
Sensitive |
| ENSG00000233725.3 |
PF-562271 |
Bladder urothelial carcinoma |
0.03836792 |
Sensitive |
| ENSG00000233775.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.03434316 |
Sensitive |
| ENSG00000234936.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.001763399 |
Sensitive |
| ENSG00000236901.3 |
PF-562271 |
Bladder urothelial carcinoma |
0.03708512 |
Sensitive |
| ENSG00000238260.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.042606366 |
Sensitive |
| ENSG00000240591.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.015850978 |
Sensitive |
| ENSG00000241520.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.045181728 |
Sensitive |
| ENSG00000242578.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.046370864 |
Sensitive |
| ENSG00000243766.3 |
PF-562271 |
Bladder urothelial carcinoma |
0.016757733 |
Sensitive |
| ENSG00000248932.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.023261423 |
Sensitive |
| ENSG00000249234.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.035344474 |
Sensitive |
| ENSG00000250122.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.041922282 |
Sensitive |
| ENSG00000251365.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.032606018 |
Sensitive |
| ENSG00000253552.3 |
PF-562271 |
Bladder urothelial carcinoma |
0.025660943 |
Sensitive |
| ENSG00000254664.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.006593718 |
Sensitive |
| ENSG00000255970.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.030136364 |
Sensitive |
| ENSG00000256588.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.038094162 |
Sensitive |
| ENSG00000257595.2 |
PF-562271 |
Bladder urothelial carcinoma |
0.006183191 |
Sensitive |
| ENSG00000257859.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.04497771 |
Sensitive |
| ENSG00000259876.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.004086895 |
Sensitive |
| ENSG00000260583.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.033714557 |
Sensitive |
| ENSG00000260837.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.003453949 |
Sensitive |
| ENSG00000261496.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.002474072 |
Sensitive |
| ENSG00000261786.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.018273893 |
Sensitive |
| ENSG00000266805.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.003591558 |
Sensitive |
| ENSG00000266895.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.042897625 |
Sensitive |
| ENSG00000267715.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.008010214 |
Sensitive |
| ENSG00000267852.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.032508929 |
Sensitive |
| ENSG00000270074.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.019759711 |
Sensitive |
| ENSG00000270419.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.026106621 |
Sensitive |
| ENSG00000271803.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.049946934 |
Sensitive |
| ENSG00000272554.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.044888736 |
Sensitive |
| ENSG00000272660.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.042389333 |
Sensitive |
| ENSG00000272754.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.025058353 |
Sensitive |
| ENSG00000272970.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.032713647 |
Sensitive |
| ENSG00000273240.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.012673074 |
Sensitive |
| ENSG00000273355.1 |
PF-562271 |
Bladder urothelial carcinoma |
0.021080693 |
Sensitive |
| ENSG00000170161.6 |
PF-562271 |
Breast invasive carcinoma |
0.01235029 |
Sensitive |
| ENSG00000183674.7 |
PF-562271 |
Breast invasive carcinoma |
0.026128109 |
Sensitive |
| ENSG00000197251.3 |
PF-562271 |
Breast invasive carcinoma |
0.021278678 |
Sensitive |
| ENSG00000203362.2 |
PF-562271 |
Breast invasive carcinoma |
0.00250356 |
Sensitive |
| ENSG00000224621.1 |
PF-562271 |
Breast invasive carcinoma |
0.031369915 |
Sensitive |
| ENSG00000224897.2 |
PF-562271 |
Breast invasive carcinoma |
0.027267904 |
Sensitive |
| ENSG00000224945.1 |
PF-562271 |
Breast invasive carcinoma |
0.008015658 |
Sensitive |
| ENSG00000226149.1 |
PF-562271 |
Breast invasive carcinoma |
0.025740278 |
Sensitive |
| ENSG00000226645.1 |
PF-562271 |
Breast invasive carcinoma |
0.006489114 |
Sensitive |
| ENSG00000227388.2 |
PF-562271 |
Breast invasive carcinoma |
0.023518858 |
Sensitive |
| ENSG00000227403.1 |
PF-562271 |
Breast invasive carcinoma |
0.034914018 |
Sensitive |
| ENSG00000227959.1 |
PF-562271 |
Breast invasive carcinoma |
0.000643955 |
Sensitive |
| ENSG00000229401.1 |
PF-562271 |
Breast invasive carcinoma |
0.000798466 |
Sensitive |
| ENSG00000231611.1 |
PF-562271 |
Breast invasive carcinoma |
0.046752009 |
Sensitive |
| ENSG00000232860.3 |
PF-562271 |
Breast invasive carcinoma |
0.03205619 |
Sensitive |
| ENSG00000233559.1 |
PF-562271 |
Breast invasive carcinoma |
0.047992614 |
Sensitive |
| ENSG00000233590.1 |
PF-562271 |
Breast invasive carcinoma |
0.022600329 |
Sensitive |
| ENSG00000234665.4 |
PF-562271 |
Breast invasive carcinoma |
0.020585641 |
Sensitive |
| ENSG00000235724.4 |
PF-562271 |
Breast invasive carcinoma |
0.024231584 |
Sensitive |
| ENSG00000236091.1 |
PF-562271 |
Breast invasive carcinoma |
0.033112843 |
Sensitive |
| ENSG00000236426.3 |
PF-562271 |
Breast invasive carcinoma |
0.044021249 |
Sensitive |
| ENSG00000237523.1 |
PF-562271 |
Breast invasive carcinoma |
0.000595713 |
Sensitive |
| ENSG00000237899.1 |
PF-562271 |
Breast invasive carcinoma |
0.030086513 |
Sensitive |
| ENSG00000242125.2 |
PF-562271 |
Breast invasive carcinoma |
0.017413163 |
Sensitive |
| ENSG00000244268.1 |
PF-562271 |
Breast invasive carcinoma |
0.048571428 |
Sensitive |
| ENSG00000249216.1 |
PF-562271 |
Breast invasive carcinoma |
0.003233192 |
Sensitive |
| ENSG00000250362.1 |
PF-562271 |
Breast invasive carcinoma |
0.029792283 |
Sensitive |
| ENSG00000253112.1 |
PF-562271 |
Breast invasive carcinoma |
0.032069895 |
Sensitive |
| ENSG00000254990.1 |
PF-562271 |
Breast invasive carcinoma |
0.012547751 |
Sensitive |
| ENSG00000255310.2 |
PF-562271 |
Breast invasive carcinoma |
0.028513692 |
Sensitive |
| ENSG00000256751.1 |
PF-562271 |
Breast invasive carcinoma |
0.036159739 |
Sensitive |
| ENSG00000260484.1 |
PF-562271 |
Breast invasive carcinoma |
0.045517725 |
Sensitive |
| ENSG00000261471.1 |
PF-562271 |
Breast invasive carcinoma |
0.000461805 |
Sensitive |
| ENSG00000261760.2 |
PF-562271 |
Breast invasive carcinoma |
0.030346052 |
Sensitive |
| ENSG00000267927.1 |
PF-562271 |
Breast invasive carcinoma |
0.018818439 |
Sensitive |
| ENSG00000268613.1 |
PF-562271 |
Breast invasive carcinoma |
0.025290882 |
Sensitive |
| ENSG00000269974.1 |
PF-562271 |
Breast invasive carcinoma |
0.038486006 |
Sensitive |
| ENSG00000271133.1 |
PF-562271 |
Breast invasive carcinoma |
0.023497495 |
Sensitive |
| ENSG00000271826.1 |
PF-562271 |
Breast invasive carcinoma |
0.01886559 |
Sensitive |
| ENSG00000272123.1 |
PF-562271 |
Breast invasive carcinoma |
0.034879217 |
Sensitive |
| ENSG00000272338.1 |
PF-562271 |
Breast invasive carcinoma |
0.010917513 |
Sensitive |
| ENSG00000272904.1 |
PF-562271 |
Breast invasive carcinoma |
0.019572041 |
Sensitive |
| ENSG00000125804.9 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.026878856 |
Sensitive |
| ENSG00000177757.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.035006273 |
Sensitive |
| ENSG00000197813.4 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.040606317 |
Sensitive |
| ENSG00000204791.4 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.014678954 |
Sensitive |
| ENSG00000215394.4 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.013895034 |
Sensitive |
| ENSG00000223576.2 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.032268514 |
Sensitive |
| ENSG00000223714.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.001821853 |
Sensitive |
| ENSG00000224050.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.030430213 |
Sensitive |
| ENSG00000225030.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.045458606 |
Sensitive |
| ENSG00000225439.2 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.035979119 |
Sensitive |
| ENSG00000226029.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.045171224 |
Sensitive |
| ENSG00000226352.2 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.037571324 |
Sensitive |
| ENSG00000227492.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.032484815 |
Sensitive |
| ENSG00000227502.2 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.002980838 |
Sensitive |
| ENSG00000227740.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.033916608 |
Sensitive |
| ENSG00000227773.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.04062224 |
Sensitive |
| ENSG00000227953.2 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.006318421 |
Sensitive |
| ENSG00000228010.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.03622769 |
Sensitive |
| ENSG00000228237.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.04797456 |
Sensitive |
| ENSG00000228389.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.040508955 |
Sensitive |
| ENSG00000228763.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.011665195 |
Sensitive |
| ENSG00000228839.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.017745494 |
Sensitive |
| ENSG00000228889.2 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.045971765 |
Sensitive |
| ENSG00000229702.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.005281378 |
Sensitive |
| ENSG00000230310.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.042328484 |
Sensitive |
| ENSG00000230565.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.03052609 |
Sensitive |
| ENSG00000231595.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.041579986 |
Sensitive |
| ENSG00000231636.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.030376601 |
Sensitive |
| ENSG00000231944.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.017959613 |
Sensitive |
| ENSG00000232729.3 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.032934211 |
Sensitive |
| ENSG00000232931.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.035541238 |
Sensitive |
| ENSG00000233061.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.04428381 |
Sensitive |
| ENSG00000233783.3 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.012436347 |
Sensitive |
| ENSG00000234290.2 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.048672096 |
Sensitive |
| ENSG00000234665.4 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.040407066 |
Sensitive |
| ENSG00000234818.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.038974317 |
Sensitive |
| ENSG00000234945.3 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.032041554 |
Sensitive |
| ENSG00000234996.3 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.013432192 |
Sensitive |
| ENSG00000235908.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.008997293 |
Sensitive |
| ENSG00000236199.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.024023807 |
Sensitive |
| ENSG00000237017.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.028736311 |
Sensitive |
| ENSG00000237903.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.008356707 |
Sensitive |
| ENSG00000238018.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.02744572 |
Sensitive |
| ENSG00000240549.2 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.042250444 |
Sensitive |
| ENSG00000242798.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.023692941 |
Sensitive |
| ENSG00000244393.3 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.015072499 |
Sensitive |
| ENSG00000245748.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.009194313 |
Sensitive |
| ENSG00000248175.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.015026425 |
Sensitive |
| ENSG00000249456.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.005890213 |
Sensitive |
| ENSG00000249635.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.035802519 |
Sensitive |
| ENSG00000250295.2 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.04682593 |
Sensitive |
| ENSG00000250909.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.013139067 |
Sensitive |
| ENSG00000251175.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.017215137 |
Sensitive |
| ENSG00000251580.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.027315556 |
Sensitive |
| ENSG00000253307.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.015071245 |
Sensitive |
| ENSG00000253392.2 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.040918233 |
Sensitive |
| ENSG00000253399.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.017193835 |
Sensitive |
| ENSG00000254263.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.041524418 |
Sensitive |
| ENSG00000255487.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.023193619 |
Sensitive |
| ENSG00000256116.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.004296255 |
Sensitive |
| ENSG00000256603.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.048080915 |
Sensitive |
| ENSG00000258355.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.016590718 |
Sensitive |
| ENSG00000258682.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.047886066 |
Sensitive |
| ENSG00000258725.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.045080605 |
Sensitive |
| ENSG00000259322.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.017660527 |
Sensitive |
| ENSG00000259595.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.001109573 |
Sensitive |
| ENSG00000259758.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.049238558 |
Sensitive |
| ENSG00000259806.2 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.025275889 |
Sensitive |
| ENSG00000260213.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.022773518 |
Sensitive |
| ENSG00000260400.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.00040818 |
Sensitive |
| ENSG00000260565.2 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.046544909 |
Sensitive |
| ENSG00000260917.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.02610424 |
Sensitive |
| ENSG00000261002.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.029194934 |
Sensitive |
| ENSG00000261064.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.042706854 |
Sensitive |
| ENSG00000261267.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.01474338 |
Sensitive |
| ENSG00000261337.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.034063972 |
Sensitive |
| ENSG00000263470.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.024791157 |
Sensitive |
| ENSG00000263727.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.00871932 |
Sensitive |
| ENSG00000264167.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.042276399 |
Sensitive |
| ENSG00000264469.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.032654116 |
Sensitive |
| ENSG00000264937.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.001500094 |
Sensitive |
| ENSG00000266236.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.012857522 |
Sensitive |
| ENSG00000266717.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.049385316 |
Sensitive |
| ENSG00000267108.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.003699838 |
Sensitive |
| ENSG00000267117.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.005626672 |
Sensitive |
| ENSG00000267491.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.045437236 |
Sensitive |
| ENSG00000267778.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.013489982 |
Sensitive |
| ENSG00000267940.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.013392814 |
Sensitive |
| ENSG00000268006.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.034178116 |
Sensitive |
| ENSG00000268081.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.040105361 |
Sensitive |
| ENSG00000269044.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.041314945 |
Sensitive |
| ENSG00000269290.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.039585696 |
Sensitive |
| ENSG00000269707.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.016336783 |
Sensitive |
| ENSG00000269910.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.035636347 |
Sensitive |
| ENSG00000269940.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.024663975 |
Sensitive |
| ENSG00000269947.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.027193586 |
Sensitive |
| ENSG00000269951.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.036336736 |
Sensitive |
| ENSG00000269958.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.044294614 |
Sensitive |
| ENSG00000269959.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.023666635 |
Sensitive |
| ENSG00000270006.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.049469326 |
Sensitive |
| ENSG00000270028.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.033725635 |
Sensitive |
| ENSG00000270062.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.0011949 |
Sensitive |
| ENSG00000270083.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.036882753 |
Sensitive |
| ENSG00000270140.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.040710362 |
Sensitive |
| ENSG00000270184.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.04072224 |
Sensitive |
| ENSG00000270580.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.015704483 |
Sensitive |
| ENSG00000271228.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.046942293 |
Sensitive |
| ENSG00000271533.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.000604645 |
Sensitive |
| ENSG00000271554.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.015847522 |
Sensitive |
| ENSG00000271843.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.03907219 |
Sensitive |
| ENSG00000271851.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.013543923 |
Sensitive |
| ENSG00000272040.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.033465238 |
Sensitive |
| ENSG00000272077.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.041934984 |
Sensitive |
| ENSG00000272148.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.046920572 |
Sensitive |
| ENSG00000272250.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.007281516 |
Sensitive |
| ENSG00000272520.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.026990232 |
Sensitive |
| ENSG00000272696.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.034214361 |
Sensitive |
| ENSG00000272764.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.034022212 |
Sensitive |
| ENSG00000272888.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.040480379 |
Sensitive |
| ENSG00000273007.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.048734308 |
Sensitive |
| ENSG00000273203.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.049577646 |
Sensitive |
| ENSG00000273302.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.01126162 |
Sensitive |
| ENSG00000273343.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.011056508 |
Sensitive |
| ENSG00000273353.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.00320396 |
Sensitive |
| ENSG00000273447.1 |
PF-562271 |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.043271371 |
Sensitive |
| ENSG00000175061.13 |
PF-562271 |
Colon adenocarcinoma |
0.030163883 |
Sensitive |
| ENSG00000179141.5 |
PF-562271 |
Colon adenocarcinoma |
0.011430519 |
Sensitive |
| ENSG00000179406.6 |
PF-562271 |
Colon adenocarcinoma |
0.007927876 |
Sensitive |
| ENSG00000179818.9 |
PF-562271 |
Colon adenocarcinoma |
0.040045491 |
Sensitive |
| ENSG00000204929.7 |
PF-562271 |
Colon adenocarcinoma |
0.022809421 |
Sensitive |
| ENSG00000205890.3 |
PF-562271 |
Colon adenocarcinoma |
0.031338944 |
Sensitive |
| ENSG00000214145.2 |
PF-562271 |
Colon adenocarcinoma |
0.01772483 |
Sensitive |
| ENSG00000214347.5 |
PF-562271 |
Colon adenocarcinoma |
0.012869291 |
Sensitive |
| ENSG00000214353.3 |
PF-562271 |
Colon adenocarcinoma |
0.024448713 |
Sensitive |
| ENSG00000214691.6 |
PF-562271 |
Colon adenocarcinoma |
0.007029166 |
Sensitive |
| ENSG00000221571.2 |
PF-562271 |
Colon adenocarcinoma |
0.022359638 |
Sensitive |
| ENSG00000221817.5 |
PF-562271 |
Colon adenocarcinoma |
0.008919841 |
Sensitive |
| ENSG00000223571.1 |
PF-562271 |
Colon adenocarcinoma |
0.003865941 |
Sensitive |
| ENSG00000223764.2 |
PF-562271 |
Colon adenocarcinoma |
0.043246297 |
Sensitive |
| ENSG00000223979.2 |
PF-562271 |
Colon adenocarcinoma |
0.005693408 |
Sensitive |
| ENSG00000224032.2 |
PF-562271 |
Colon adenocarcinoma |
0.027563357 |
Sensitive |
| ENSG00000224292.1 |
PF-562271 |
Colon adenocarcinoma |
0.045529004 |
Sensitive |
| ENSG00000224356.3 |
PF-562271 |
Colon adenocarcinoma |
0.016893478 |
Sensitive |
| ENSG00000225083.1 |
PF-562271 |
Colon adenocarcinoma |
0.038567802 |
Sensitive |
| ENSG00000225173.1 |
PF-562271 |
Colon adenocarcinoma |
0.003778438 |
Sensitive |
| ENSG00000225377.1 |
PF-562271 |
Colon adenocarcinoma |
0.025285389 |
Sensitive |
| ENSG00000225548.1 |
PF-562271 |
Colon adenocarcinoma |
0.009853162 |
Sensitive |
| ENSG00000225836.1 |
PF-562271 |
Colon adenocarcinoma |
0.010184635 |
Sensitive |
| ENSG00000226352.2 |
PF-562271 |
Colon adenocarcinoma |
0.045485224 |
Sensitive |
| ENSG00000226453.1 |
PF-562271 |
Colon adenocarcinoma |
0.020788251 |
Sensitive |
| ENSG00000226862.1 |
PF-562271 |
Colon adenocarcinoma |
0.015084227 |
Sensitive |
| ENSG00000227953.2 |
PF-562271 |
Colon adenocarcinoma |
0.013988229 |
Sensitive |
| ENSG00000228274.3 |
PF-562271 |
Colon adenocarcinoma |
0.040788411 |
Sensitive |
| ENSG00000228549.2 |
PF-562271 |
Colon adenocarcinoma |
0.037884981 |
Sensitive |
| ENSG00000228886.1 |
PF-562271 |
Colon adenocarcinoma |
0.021814725 |
Sensitive |
| ENSG00000229105.1 |
PF-562271 |
Colon adenocarcinoma |
0.016447298 |
Sensitive |
| ENSG00000229191.1 |
PF-562271 |
Colon adenocarcinoma |
0.035924461 |
Sensitive |
| ENSG00000229970.3 |
PF-562271 |
Colon adenocarcinoma |
0.036418807 |
Sensitive |
| ENSG00000230615.2 |
PF-562271 |
Colon adenocarcinoma |
0.0000563 |
Sensitive |
| ENSG00000230679.1 |
PF-562271 |
Colon adenocarcinoma |
0.046363139 |
Sensitive |
| ENSG00000231521.1 |
PF-562271 |
Colon adenocarcinoma |
0.007865187 |
Sensitive |
| ENSG00000231646.1 |
PF-562271 |
Colon adenocarcinoma |
0.008909497 |
Sensitive |
| ENSG00000232470.1 |
PF-562271 |
Colon adenocarcinoma |
0.049806992 |
Sensitive |
| ENSG00000232656.3 |
PF-562271 |
Colon adenocarcinoma |
0.00945335 |
Sensitive |
| ENSG00000232936.1 |
PF-562271 |
Colon adenocarcinoma |
0.046502998 |
Sensitive |
| ENSG00000233242.2 |
PF-562271 |
Colon adenocarcinoma |
0.001869949 |
Sensitive |
| ENSG00000233627.2 |
PF-562271 |
Colon adenocarcinoma |
0.042538084 |
Sensitive |
| ENSG00000234139.2 |
PF-562271 |
Colon adenocarcinoma |
0.012220898 |
Sensitive |
| ENSG00000234694.1 |
PF-562271 |
Colon adenocarcinoma |
0.007335003 |
Sensitive |
| ENSG00000235072.1 |
PF-562271 |
Colon adenocarcinoma |
0.028200634 |
Sensitive |
| ENSG00000235326.1 |
PF-562271 |
Colon adenocarcinoma |
0.021216542 |
Sensitive |
| ENSG00000235560.3 |
PF-562271 |
Colon adenocarcinoma |
0.010763335 |
Sensitive |
| ENSG00000235831.2 |
PF-562271 |
Colon adenocarcinoma |
0.046387573 |
Sensitive |
| ENSG00000236051.2 |
PF-562271 |
Colon adenocarcinoma |
0.027835701 |
Sensitive |
| ENSG00000236266.1 |
PF-562271 |
Colon adenocarcinoma |
0.015234552 |
Sensitive |
| ENSG00000236438.2 |
PF-562271 |
Colon adenocarcinoma |
0.011839406 |
Sensitive |
| ENSG00000236991.2 |
PF-562271 |
Colon adenocarcinoma |
0.03108119 |
Sensitive |
| ENSG00000237021.2 |
PF-562271 |
Colon adenocarcinoma |
0.045144326 |
Sensitive |
| ENSG00000237248.3 |
PF-562271 |
Colon adenocarcinoma |
0.005819281 |
Sensitive |
| ENSG00000240541.2 |
PF-562271 |
Colon adenocarcinoma |
0.03314066 |
Sensitive |
| ENSG00000240990.5 |
PF-562271 |
Colon adenocarcinoma |
0.019108198 |
Sensitive |
| ENSG00000242349.1 |
PF-562271 |
Colon adenocarcinoma |
0.032053513 |
Sensitive |
| ENSG00000244945.1 |
PF-562271 |
Colon adenocarcinoma |
0.039599901 |
Sensitive |
| ENSG00000245059.2 |
PF-562271 |
Colon adenocarcinoma |
0.028768246 |
Sensitive |
| ENSG00000245330.4 |
PF-562271 |
Colon adenocarcinoma |
0.036833183 |
Sensitive |
| ENSG00000245711.2 |
PF-562271 |
Colon adenocarcinoma |
0.019452982 |
Sensitive |
| ENSG00000246323.2 |
PF-562271 |
Colon adenocarcinoma |
0.032229967 |
Sensitive |
| ENSG00000246331.2 |
PF-562271 |
Colon adenocarcinoma |
0.016481812 |
Sensitive |
| ENSG00000247853.2 |
PF-562271 |
Colon adenocarcinoma |
0.043451468 |
Sensitive |
| ENSG00000248243.1 |
PF-562271 |
Colon adenocarcinoma |
0.015947131 |
Sensitive |
| ENSG00000249464.1 |
PF-562271 |
Colon adenocarcinoma |
0.046758306 |
Sensitive |
| ENSG00000249492.1 |
PF-562271 |
Colon adenocarcinoma |
0.017523087 |
Sensitive |
| ENSG00000249655.1 |
PF-562271 |
Colon adenocarcinoma |
0.00704583 |
Sensitive |
| ENSG00000250061.1 |
PF-562271 |
Colon adenocarcinoma |
0.022158073 |
Sensitive |
| ENSG00000250069.1 |
PF-562271 |
Colon adenocarcinoma |
0.013596985 |
Sensitive |
| ENSG00000250302.1 |
PF-562271 |
Colon adenocarcinoma |
0.031370572 |
Sensitive |
| ENSG00000250546.1 |
PF-562271 |
Colon adenocarcinoma |
0.010202678 |
Sensitive |
| ENSG00000250900.2 |
PF-562271 |
Colon adenocarcinoma |
0.000161902 |
Sensitive |
| ENSG00000250903.4 |
PF-562271 |
Colon adenocarcinoma |
0.007015212 |
Sensitive |
| ENSG00000251526.1 |
PF-562271 |
Colon adenocarcinoma |
0.006416689 |
Sensitive |
| ENSG00000251675.1 |
PF-562271 |
Colon adenocarcinoma |
0.029444101 |
Sensitive |
| ENSG00000253764.1 |
PF-562271 |
Colon adenocarcinoma |
0.014001917 |
Sensitive |
| ENSG00000253865.1 |
PF-562271 |
Colon adenocarcinoma |
0.036421231 |
Sensitive |
| ENSG00000254267.1 |
PF-562271 |
Colon adenocarcinoma |
0.031867763 |
Sensitive |
| ENSG00000254341.1 |
PF-562271 |
Colon adenocarcinoma |
0.03272188 |
Sensitive |
| ENSG00000255847.1 |
PF-562271 |
Colon adenocarcinoma |
0.022347015 |
Sensitive |
| ENSG00000256008.1 |
PF-562271 |
Colon adenocarcinoma |
0.044472086 |
Sensitive |
| ENSG00000256546.1 |
PF-562271 |
Colon adenocarcinoma |
0.012962526 |
Sensitive |
| ENSG00000256789.1 |
PF-562271 |
Colon adenocarcinoma |
0.004164274 |
Sensitive |
| ENSG00000257534.1 |
PF-562271 |
Colon adenocarcinoma |
0.035892549 |
Sensitive |
| ENSG00000258811.1 |
PF-562271 |
Colon adenocarcinoma |
0.047917461 |
Sensitive |
| ENSG00000259163.1 |
PF-562271 |
Colon adenocarcinoma |
0.038867741 |
Sensitive |
| ENSG00000259206.1 |
PF-562271 |
Colon adenocarcinoma |
0.02931736 |
Sensitive |
| ENSG00000259225.2 |
PF-562271 |
Colon adenocarcinoma |
0.0435098 |
Sensitive |
| ENSG00000259310.1 |
PF-562271 |
Colon adenocarcinoma |
0.030467166 |
Sensitive |
| ENSG00000259396.1 |
PF-562271 |
Colon adenocarcinoma |
0.048832783 |
Sensitive |
| ENSG00000259709.1 |
PF-562271 |
Colon adenocarcinoma |
0.020446501 |
Sensitive |
| ENSG00000259772.2 |
PF-562271 |
Colon adenocarcinoma |
0.048170801 |
Sensitive |
| ENSG00000260088.1 |
PF-562271 |
Colon adenocarcinoma |
0.019438696 |
Sensitive |
| ENSG00000260306.1 |
PF-562271 |
Colon adenocarcinoma |
0.033755579 |
Sensitive |
| ENSG00000260855.1 |
PF-562271 |
Colon adenocarcinoma |
0.034755223 |
Sensitive |
| ENSG00000260949.1 |
PF-562271 |
Colon adenocarcinoma |
0.016750284 |
Sensitive |
| ENSG00000261003.1 |
PF-562271 |
Colon adenocarcinoma |
0.022284367 |
Sensitive |
| ENSG00000261124.1 |
PF-562271 |
Colon adenocarcinoma |
0.043372483 |
Sensitive |
| ENSG00000261266.1 |
PF-562271 |
Colon adenocarcinoma |
0.020467707 |
Sensitive |
| ENSG00000261326.2 |
PF-562271 |
Colon adenocarcinoma |
0.021707 |
Sensitive |
| ENSG00000261433.1 |
PF-562271 |
Colon adenocarcinoma |
0.011747122 |
Sensitive |
| ENSG00000261542.1 |
PF-562271 |
Colon adenocarcinoma |
0.003710045 |
Sensitive |
| ENSG00000261574.1 |
PF-562271 |
Colon adenocarcinoma |
0.002615875 |
Sensitive |
| ENSG00000261916.1 |
PF-562271 |
Colon adenocarcinoma |
0.046601367 |
Sensitive |
| ENSG00000261996.1 |
PF-562271 |
Colon adenocarcinoma |
0.00167286 |
Sensitive |
| ENSG00000262434.1 |
PF-562271 |
Colon adenocarcinoma |
0.042931211 |
Sensitive |
| ENSG00000262482.1 |
PF-562271 |
Colon adenocarcinoma |
0.043206597 |
Sensitive |
| ENSG00000263004.1 |
PF-562271 |
Colon adenocarcinoma |
0.014772482 |
Sensitive |
| ENSG00000263120.1 |
PF-562271 |
Colon adenocarcinoma |
0.022503699 |
Sensitive |
| ENSG00000263272.1 |
PF-562271 |
Colon adenocarcinoma |
0.010416426 |
Sensitive |
| ENSG00000263280.1 |
PF-562271 |
Colon adenocarcinoma |
0.041186405 |
Sensitive |
| ENSG00000263293.1 |
PF-562271 |
Colon adenocarcinoma |
0.046716716 |
Sensitive |
| ENSG00000263338.1 |
PF-562271 |
Colon adenocarcinoma |
0.048876479 |
Sensitive |
| ENSG00000263345.1 |
PF-562271 |
Colon adenocarcinoma |
0.029510272 |
Sensitive |
| ENSG00000264290.1 |
PF-562271 |
Colon adenocarcinoma |
0.036019098 |
Sensitive |
| ENSG00000264548.1 |
PF-562271 |
Colon adenocarcinoma |
0.009631955 |
Sensitive |
| ENSG00000264860.1 |
PF-562271 |
Colon adenocarcinoma |
0.016764233 |
Sensitive |
| ENSG00000264932.2 |
PF-562271 |
Colon adenocarcinoma |
0.013565704 |
Sensitive |
| ENSG00000265443.1 |
PF-562271 |
Colon adenocarcinoma |
0.001791006 |
Sensitive |
| ENSG00000265791.1 |
PF-562271 |
Colon adenocarcinoma |
0.042301859 |
Sensitive |
| ENSG00000265908.1 |
PF-562271 |
Colon adenocarcinoma |
0.007689687 |
Sensitive |
| ENSG00000265912.1 |
PF-562271 |
Colon adenocarcinoma |
0.046810154 |
Sensitive |
| ENSG00000266313.1 |
PF-562271 |
Colon adenocarcinoma |
0.018110114 |
Sensitive |
| ENSG00000266456.1 |
PF-562271 |
Colon adenocarcinoma |
0.036976743 |
Sensitive |
| ENSG00000266821.1 |
PF-562271 |
Colon adenocarcinoma |
0.011639476 |
Sensitive |
| ENSG00000267302.1 |
PF-562271 |
Colon adenocarcinoma |
0.018592546 |
Sensitive |
| ENSG00000268027.1 |
PF-562271 |
Colon adenocarcinoma |
0.025913651 |
Sensitive |
| ENSG00000270031.1 |
PF-562271 |
Colon adenocarcinoma |
0.011735674 |
Sensitive |
| ENSG00000270081.1 |
PF-562271 |
Colon adenocarcinoma |
0.019668129 |
Sensitive |
| ENSG00000270720.1 |
PF-562271 |
Colon adenocarcinoma |
0.022878025 |
Sensitive |
| ENSG00000271757.1 |
PF-562271 |
Colon adenocarcinoma |
0.003659388 |
Sensitive |
| ENSG00000271788.1 |
PF-562271 |
Colon adenocarcinoma |
0.014690812 |
Sensitive |
| ENSG00000272128.1 |
PF-562271 |
Colon adenocarcinoma |
0.008183165 |
Sensitive |
| ENSG00000272156.1 |
PF-562271 |
Colon adenocarcinoma |
0.023974619 |
Sensitive |
| ENSG00000272225.1 |
PF-562271 |
Colon adenocarcinoma |
0.045412818 |
Sensitive |
| ENSG00000272369.1 |
PF-562271 |
Colon adenocarcinoma |
0.007540868 |
Sensitive |
| ENSG00000272420.1 |
PF-562271 |
Colon adenocarcinoma |
0.027346635 |
Sensitive |
| ENSG00000272498.1 |
PF-562271 |
Colon adenocarcinoma |
0.000651188 |
Sensitive |
| ENSG00000272518.1 |
PF-562271 |
Colon adenocarcinoma |
0.03876873 |
Sensitive |
| ENSG00000272562.1 |
PF-562271 |
Colon adenocarcinoma |
0.046963149 |
Sensitive |
| ENSG00000272576.1 |
PF-562271 |
Colon adenocarcinoma |
0.029373729 |
Sensitive |
| ENSG00000272659.1 |
PF-562271 |
Colon adenocarcinoma |
0.004396382 |
Sensitive |
| ENSG00000272720.1 |
PF-562271 |
Colon adenocarcinoma |
0.026004154 |
Sensitive |
| ENSG00000272904.1 |
PF-562271 |
Colon adenocarcinoma |
0.025795873 |
Sensitive |
| ENSG00000273232.1 |
PF-562271 |
Colon adenocarcinoma |
0.02031666 |
Sensitive |
| ENSG00000273367.1 |
PF-562271 |
Colon adenocarcinoma |
0.005644871 |
Sensitive |
| ENSG00000273402.1 |
PF-562271 |
Colon adenocarcinoma |
0.020426178 |
Sensitive |
| ENSG00000167117.4 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046041115 |
Sensitive |
| ENSG00000223462.2 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014917283 |
Sensitive |
| ENSG00000229167.1 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028478919 |
Sensitive |
| ENSG00000229267.2 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049784139 |
Sensitive |
| ENSG00000233191.1 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026107675 |
Sensitive |
| ENSG00000233852.1 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.00655785 |
Sensitive |
| ENSG00000234492.4 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046520191 |
Sensitive |
| ENSG00000234707.2 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031796259 |
Sensitive |
| ENSG00000235802.1 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032123009 |
Sensitive |
| ENSG00000236947.1 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027669066 |
Sensitive |
| ENSG00000244791.2 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025693751 |
Sensitive |
| ENSG00000251432.2 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045571297 |
Sensitive |
| ENSG00000251603.1 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007702362 |
Sensitive |
| ENSG00000254664.1 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049724785 |
Sensitive |
| ENSG00000257999.1 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04748296 |
Sensitive |
| ENSG00000260833.2 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03089075 |
Sensitive |
| ENSG00000264520.1 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022748089 |
Sensitive |
| ENSG00000267924.1 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045727974 |
Sensitive |
| ENSG00000272695.1 |
PF-562271 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041696306 |
Sensitive |
| ENSG00000197462.3 |
PF-562271 |
Esophageal cancer |
0.034595728 |
Sensitive |
| ENSG00000204528.3 |
PF-562271 |
Esophageal cancer |
0.007237958 |
Sensitive |
| ENSG00000225205.1 |
PF-562271 |
Esophageal cancer |
0.032657695 |
Sensitive |
| ENSG00000225527.1 |
PF-562271 |
Esophageal cancer |
0.004611228 |
Sensitive |
| ENSG00000231711.2 |
PF-562271 |
Esophageal cancer |
0.03847221 |
Sensitive |
| ENSG00000232788.1 |
PF-562271 |
Esophageal cancer |
0.038869631 |
Sensitive |
| ENSG00000233008.1 |
PF-562271 |
Esophageal cancer |
0.034485318 |
Sensitive |
| ENSG00000236333.3 |
PF-562271 |
Esophageal cancer |
0.032075267 |
Sensitive |
| ENSG00000238280.1 |
PF-562271 |
Esophageal cancer |
0.009854133 |
Sensitive |
| ENSG00000244676.1 |
PF-562271 |
Esophageal cancer |
0.0000876 |
Sensitive |
| ENSG00000250893.1 |
PF-562271 |
Esophageal cancer |
0.049716777 |
Sensitive |
| ENSG00000254204.1 |
PF-562271 |
Esophageal cancer |
0.01402382 |
Sensitive |
| ENSG00000255856.1 |
PF-562271 |
Esophageal cancer |
0.033822028 |
Sensitive |
| ENSG00000263859.1 |
PF-562271 |
Esophageal cancer |
0.046763725 |
Sensitive |
| ENSG00000270607.1 |
PF-562271 |
Esophageal cancer |
0.019221174 |
Sensitive |
| ENSG00000272192.1 |
PF-562271 |
Esophageal cancer |
0.017502553 |
Sensitive |
| ENSG00000272520.1 |
PF-562271 |
Esophageal cancer |
0.012596377 |
Sensitive |
| ENSG00000224078.8 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.034982157 |
Sensitive |
| ENSG00000230068.2 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.021948913 |
Sensitive |
| ENSG00000231566.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.042914342 |
Sensitive |
| ENSG00000235927.2 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.029427259 |
Sensitive |
| ENSG00000255495.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.031850891 |
Sensitive |
| ENSG00000257151.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.029998653 |
Sensitive |
| ENSG00000259062.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.0489109 |
Sensitive |
| ENSG00000261131.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.040106544 |
Sensitive |
| ENSG00000261731.2 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.044192366 |
Sensitive |
| ENSG00000269910.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.026765125 |
Sensitive |
| ENSG00000269940.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.016888077 |
Sensitive |
| ENSG00000269958.1 |
PF-562271 |
Kidney renal clear cell carcinoma |
0.026937043 |
Sensitive |
| ENSG00000175772.10 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.040750786 |
Sensitive |
| ENSG00000204588.5 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.046106655 |
Sensitive |
| ENSG00000223660.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.047932218 |
Sensitive |
| ENSG00000224638.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.027018359 |
Sensitive |
| ENSG00000225218.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.0141984 |
Sensitive |
| ENSG00000228817.3 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.013347812 |
Sensitive |
| ENSG00000231705.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.004469202 |
Sensitive |
| ENSG00000236643.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.014208084 |
Sensitive |
| ENSG00000236824.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.035481247 |
Sensitive |
| ENSG00000237705.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.033447769 |
Sensitive |
| ENSG00000239911.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.034552486 |
Sensitive |
| ENSG00000244380.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.016635901 |
Sensitive |
| ENSG00000248115.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.032798612 |
Sensitive |
| ENSG00000249807.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.023201214 |
Sensitive |
| ENSG00000250267.2 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.024985723 |
Sensitive |
| ENSG00000253603.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.039781838 |
Sensitive |
| ENSG00000255672.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.039738502 |
Sensitive |
| ENSG00000258813.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.003048778 |
Sensitive |
| ENSG00000259583.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.035838146 |
Sensitive |
| ENSG00000260190.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.033689407 |
Sensitive |
| ENSG00000260196.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.04957428 |
Sensitive |
| ENSG00000260898.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.046433572 |
Sensitive |
| ENSG00000262185.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.047737174 |
Sensitive |
| ENSG00000262339.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.037431095 |
Sensitive |
| ENSG00000263731.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.04436282 |
Sensitive |
| ENSG00000265750.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.008673421 |
Sensitive |
| ENSG00000266256.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.020097863 |
Sensitive |
| ENSG00000266312.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.045722636 |
Sensitive |
| ENSG00000266821.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.000187416 |
Sensitive |
| ENSG00000267130.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.010930153 |
Sensitive |
| ENSG00000267296.2 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.04609757 |
Sensitive |
| ENSG00000267475.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.015607076 |
Sensitive |
| ENSG00000268568.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.039655138 |
Sensitive |
| ENSG00000269898.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.030252787 |
Sensitive |
| ENSG00000269924.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.046887825 |
Sensitive |
| ENSG00000270640.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.025303266 |
Sensitive |
| ENSG00000271631.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.038069618 |
Sensitive |
| ENSG00000271781.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.016754205 |
Sensitive |
| ENSG00000272361.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.026328862 |
Sensitive |
| ENSG00000272377.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.027791355 |
Sensitive |
| ENSG00000272556.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.002460079 |
Sensitive |
| ENSG00000272859.1 |
PF-562271 |
Chronic Lymphocytic Leukemia |
0.022821499 |
Sensitive |
| ENSG00000223635.1 |
PF-562271 |
Brain lower grade glioma |
0.033866484 |
Sensitive |
| ENSG00000225969.1 |
PF-562271 |
Brain lower grade glioma |
0.022790244 |
Sensitive |
| ENSG00000226287.3 |
PF-562271 |
Brain lower grade glioma |
0.029348815 |
Sensitive |
| ENSG00000227070.1 |
PF-562271 |
Brain lower grade glioma |
0.03566216 |
Sensitive |
| ENSG00000227155.3 |
PF-562271 |
Brain lower grade glioma |
0.042729068 |
Sensitive |
| ENSG00000228322.1 |
PF-562271 |
Brain lower grade glioma |
0.024902197 |
Sensitive |
| ENSG00000230649.2 |
PF-562271 |
Brain lower grade glioma |
0.029083412 |
Sensitive |
| ENSG00000231187.2 |
PF-562271 |
Brain lower grade glioma |
0.024299554 |
Sensitive |
| ENSG00000231536.1 |
PF-562271 |
Brain lower grade glioma |
0.030477636 |
Sensitive |
| ENSG00000231713.2 |
PF-562271 |
Brain lower grade glioma |
0.04082942 |
Sensitive |
| ENSG00000231908.1 |
PF-562271 |
Brain lower grade glioma |
0.027010745 |
Sensitive |
| ENSG00000232530.1 |
PF-562271 |
Brain lower grade glioma |
0.045257316 |
Sensitive |
| ENSG00000235823.1 |
PF-562271 |
Brain lower grade glioma |
0.013244986 |
Sensitive |
| ENSG00000240005.1 |
PF-562271 |
Brain lower grade glioma |
0.028342962 |
Sensitive |
| ENSG00000242078.1 |
PF-562271 |
Brain lower grade glioma |
0.026810752 |
Sensitive |
| ENSG00000243479.3 |
PF-562271 |
Brain lower grade glioma |
0.016046467 |
Sensitive |
| ENSG00000247095.2 |
PF-562271 |
Brain lower grade glioma |
0.03295536 |
Sensitive |
| ENSG00000248787.1 |
PF-562271 |
Brain lower grade glioma |
0.023568192 |
Sensitive |
| ENSG00000254003.1 |
PF-562271 |
Brain lower grade glioma |
0.030125945 |
Sensitive |
| ENSG00000255241.1 |
PF-562271 |
Brain lower grade glioma |
0.019337087 |
Sensitive |
| ENSG00000257261.1 |
PF-562271 |
Brain lower grade glioma |
0.038774709 |
Sensitive |
| ENSG00000258410.1 |
PF-562271 |
Brain lower grade glioma |
0.009887788 |
Sensitive |
| ENSG00000260466.1 |
PF-562271 |
Brain lower grade glioma |
0.040503296 |
Sensitive |
| ENSG00000260651.1 |
PF-562271 |
Brain lower grade glioma |
0.047183254 |
Sensitive |
| ENSG00000261238.1 |
PF-562271 |
Brain lower grade glioma |
0.027523303 |
Sensitive |
| ENSG00000262089.1 |
PF-562271 |
Brain lower grade glioma |
0.019141738 |
Sensitive |
| ENSG00000262668.1 |
PF-562271 |
Brain lower grade glioma |
0.042969906 |
Sensitive |
| ENSG00000262810.1 |
PF-562271 |
Brain lower grade glioma |
0.003561686 |
Sensitive |
| ENSG00000262823.1 |
PF-562271 |
Brain lower grade glioma |
0.044544637 |
Sensitive |
| ENSG00000266473.1 |
PF-562271 |
Brain lower grade glioma |
0.045860194 |
Sensitive |
| ENSG00000266970.1 |
PF-562271 |
Brain lower grade glioma |
0.018713383 |
Sensitive |
| ENSG00000267547.1 |
PF-562271 |
Brain lower grade glioma |
0.044044906 |
Sensitive |
| ENSG00000267919.1 |
PF-562271 |
Brain lower grade glioma |
0.007030712 |
Sensitive |
| ENSG00000267939.1 |
PF-562271 |
Brain lower grade glioma |
0.034626626 |
Sensitive |
| ENSG00000268650.3 |
PF-562271 |
Brain lower grade glioma |
0.024770871 |
Sensitive |
| ENSG00000272369.1 |
PF-562271 |
Brain lower grade glioma |
0.037793547 |
Sensitive |
| ENSG00000171889.3 |
PF-562271 |
Lung squamous cell carcinoma |
0.039488417 |
Sensitive |
| ENSG00000183535.5 |
PF-562271 |
Lung squamous cell carcinoma |
0.047923769 |
Sensitive |
| ENSG00000214407.3 |
PF-562271 |
Lung squamous cell carcinoma |
0.033811291 |
Sensitive |
| ENSG00000215244.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.00075664 |
Sensitive |
| ENSG00000223387.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.018956119 |
Sensitive |
| ENSG00000223525.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.015479191 |
Sensitive |
| ENSG00000224409.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.030877315 |
Sensitive |
| ENSG00000224574.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.035290202 |
Sensitive |
| ENSG00000224733.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.032054886 |
Sensitive |
| ENSG00000224794.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.04949723 |
Sensitive |
| ENSG00000224961.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.035188322 |
Sensitive |
| ENSG00000225684.3 |
PF-562271 |
Lung squamous cell carcinoma |
0.041537238 |
Sensitive |
| ENSG00000225790.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.02315428 |
Sensitive |
| ENSG00000226101.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.033513899 |
Sensitive |
| ENSG00000226526.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.028712872 |
Sensitive |
| ENSG00000227502.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.047563079 |
Sensitive |
| ENSG00000227925.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.013524177 |
Sensitive |
| ENSG00000228033.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.049260562 |
Sensitive |
| ENSG00000228437.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.008193399 |
Sensitive |
| ENSG00000228742.5 |
PF-562271 |
Lung squamous cell carcinoma |
0.038923465 |
Sensitive |
| ENSG00000229056.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.041825639 |
Sensitive |
| ENSG00000229124.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.027109387 |
Sensitive |
| ENSG00000229642.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.030290265 |
Sensitive |
| ENSG00000230427.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.035967864 |
Sensitive |
| ENSG00000230438.5 |
PF-562271 |
Lung squamous cell carcinoma |
0.030474402 |
Sensitive |
| ENSG00000230479.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.038335628 |
Sensitive |
| ENSG00000231290.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.041869991 |
Sensitive |
| ENSG00000231291.3 |
PF-562271 |
Lung squamous cell carcinoma |
0.042689104 |
Sensitive |
| ENSG00000231298.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.047050526 |
Sensitive |
| ENSG00000231528.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.037655665 |
Sensitive |
| ENSG00000231652.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.024086909 |
Sensitive |
| ENSG00000231811.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.045553009 |
Sensitive |
| ENSG00000232386.5 |
PF-562271 |
Lung squamous cell carcinoma |
0.039651064 |
Sensitive |
| ENSG00000232498.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.025592781 |
Sensitive |
| ENSG00000232934.3 |
PF-562271 |
Lung squamous cell carcinoma |
0.035792768 |
Sensitive |
| ENSG00000233009.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.042033753 |
Sensitive |
| ENSG00000233117.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.039137979 |
Sensitive |
| ENSG00000233818.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.019143001 |
Sensitive |
| ENSG00000234199.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.03212274 |
Sensitive |
| ENSG00000234899.5 |
PF-562271 |
Lung squamous cell carcinoma |
0.025625163 |
Sensitive |
| ENSG00000235005.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.033244325 |
Sensitive |
| ENSG00000235387.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.043598386 |
Sensitive |
| ENSG00000235820.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.036988751 |
Sensitive |
| ENSG00000235884.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.027980891 |
Sensitive |
| ENSG00000236799.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.027848935 |
Sensitive |
| ENSG00000236838.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.016645887 |
Sensitive |
| ENSG00000237768.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.004323271 |
Sensitive |
| ENSG00000237807.3 |
PF-562271 |
Lung squamous cell carcinoma |
0.015628421 |
Sensitive |
| ENSG00000237851.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.043516364 |
Sensitive |
| ENSG00000238042.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.006701269 |
Sensitive |
| ENSG00000240198.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.032542377 |
Sensitive |
| ENSG00000240541.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.018116161 |
Sensitive |
| ENSG00000240922.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.031061644 |
Sensitive |
| ENSG00000241280.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.041344136 |
Sensitive |
| ENSG00000241985.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.031002803 |
Sensitive |
| ENSG00000244268.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.033756735 |
Sensitive |
| ENSG00000246731.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.037615129 |
Sensitive |
| ENSG00000248125.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.014811319 |
Sensitive |
| ENSG00000248131.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.046738598 |
Sensitive |
| ENSG00000248494.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.019551447 |
Sensitive |
| ENSG00000248690.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.01315926 |
Sensitive |
| ENSG00000249599.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.04042532 |
Sensitive |
| ENSG00000250608.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.002532506 |
Sensitive |
| ENSG00000251194.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.046632655 |
Sensitive |
| ENSG00000253405.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.04253101 |
Sensitive |
| ENSG00000253968.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.011801218 |
Sensitive |
| ENSG00000254142.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.016322943 |
Sensitive |
| ENSG00000254154.4 |
PF-562271 |
Lung squamous cell carcinoma |
0.034860381 |
Sensitive |
| ENSG00000254204.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.018741676 |
Sensitive |
| ENSG00000254418.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.04952116 |
Sensitive |
| ENSG00000254592.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.02351148 |
Sensitive |
| ENSG00000254688.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.028045547 |
Sensitive |
| ENSG00000255089.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.047133054 |
Sensitive |
| ENSG00000255100.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.040631416 |
Sensitive |
| ENSG00000255269.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.042928151 |
Sensitive |
| ENSG00000255327.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.048128535 |
Sensitive |
| ENSG00000255438.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.044367418 |
Sensitive |
| ENSG00000255521.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.008077666 |
Sensitive |
| ENSG00000256268.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.047307913 |
Sensitive |
| ENSG00000256802.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.031068237 |
Sensitive |
| ENSG00000257058.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.003468002 |
Sensitive |
| ENSG00000257097.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.026230197 |
Sensitive |
| ENSG00000257702.3 |
PF-562271 |
Lung squamous cell carcinoma |
0.008414211 |
Sensitive |
| ENSG00000258461.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.028567404 |
Sensitive |
| ENSG00000258537.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.02879342 |
Sensitive |
| ENSG00000258602.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.046170655 |
Sensitive |
| ENSG00000258914.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.045860543 |
Sensitive |
| ENSG00000258929.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.022793628 |
Sensitive |
| ENSG00000258955.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.010650199 |
Sensitive |
| ENSG00000259473.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.031810269 |
Sensitive |
| ENSG00000259712.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.019386113 |
Sensitive |
| ENSG00000259735.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.019366496 |
Sensitive |
| ENSG00000260454.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.042520156 |
Sensitive |
| ENSG00000261273.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.009432662 |
Sensitive |
| ENSG00000261298.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.049962335 |
Sensitive |
| ENSG00000261662.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.027738806 |
Sensitive |
| ENSG00000261838.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.013577524 |
Sensitive |
| ENSG00000263293.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.021287709 |
Sensitive |
| ENSG00000263893.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.047730057 |
Sensitive |
| ENSG00000264026.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.040331906 |
Sensitive |
| ENSG00000264448.2 |
PF-562271 |
Lung squamous cell carcinoma |
0.028852524 |
Sensitive |
| ENSG00000264513.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.024510305 |
Sensitive |
| ENSG00000265666.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.025375766 |
Sensitive |
| ENSG00000266278.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.03608755 |
Sensitive |
| ENSG00000266554.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.036132421 |
Sensitive |
| ENSG00000267123.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.036943522 |
Sensitive |
| ENSG00000267747.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.049129051 |
Sensitive |
| ENSG00000268655.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.02605953 |
Sensitive |
| ENSG00000270000.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.044205518 |
Sensitive |
| ENSG00000271857.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.01359426 |
Sensitive |
| ENSG00000271943.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.023610579 |
Sensitive |
| ENSG00000272046.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.017911567 |
Sensitive |
| ENSG00000272236.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.020363648 |
Sensitive |
| ENSG00000272397.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.042147053 |
Sensitive |
| ENSG00000272763.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.036218354 |
Sensitive |
| ENSG00000272808.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.047725118 |
Sensitive |
| ENSG00000272824.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.002889237 |
Sensitive |
| ENSG00000273065.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.009950584 |
Sensitive |
| ENSG00000273209.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.046480184 |
Sensitive |
| ENSG00000273348.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.004458622 |
Sensitive |
| ENSG00000273443.1 |
PF-562271 |
Lung squamous cell carcinoma |
0.045428277 |
Sensitive |
| ENSG00000171889.3 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.033113894 |
Sensitive |
| ENSG00000185203.7 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.038437738 |
Sensitive |
| ENSG00000222043.2 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.010961157 |
Sensitive |
| ENSG00000223356.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.013498735 |
Sensitive |
| ENSG00000224687.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.008748813 |
Sensitive |
| ENSG00000224843.2 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.041717638 |
Sensitive |
| ENSG00000226786.2 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.031156861 |
Sensitive |
| ENSG00000227740.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.027748808 |
Sensitive |
| ENSG00000228801.5 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.04187787 |
Sensitive |
| ENSG00000231119.2 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.039272377 |
Sensitive |
| ENSG00000231324.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.049881797 |
Sensitive |
| ENSG00000231574.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.019739206 |
Sensitive |
| ENSG00000231628.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.046204865 |
Sensitive |
| ENSG00000231794.3 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.033371075 |
Sensitive |
| ENSG00000232139.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.042496766 |
Sensitive |
| ENSG00000232295.3 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.038079136 |
Sensitive |
| ENSG00000233559.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.017685416 |
Sensitive |
| ENSG00000233817.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.046192555 |
Sensitive |
| ENSG00000233912.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.031172569 |
Sensitive |
| ENSG00000235277.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.040435604 |
Sensitive |
| ENSG00000235313.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.021879052 |
Sensitive |
| ENSG00000235398.4 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.011739741 |
Sensitive |
| ENSG00000236384.3 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.048697043 |
Sensitive |
| ENSG00000237886.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.021202505 |
Sensitive |
| ENSG00000240990.5 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.025056697 |
Sensitive |
| ENSG00000244558.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.037844911 |
Sensitive |
| ENSG00000251381.2 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.012886779 |
Sensitive |
| ENSG00000251661.3 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.021587739 |
Sensitive |
| ENSG00000253948.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.005373098 |
Sensitive |
| ENSG00000253961.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.035399485 |
Sensitive |
| ENSG00000257114.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.043249106 |
Sensitive |
| ENSG00000257264.2 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.036149316 |
Sensitive |
| ENSG00000257391.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.048163233 |
Sensitive |
| ENSG00000258048.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.001482251 |
Sensitive |
| ENSG00000258457.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.048974902 |
Sensitive |
| ENSG00000259758.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.014825695 |
Sensitive |
| ENSG00000260273.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.008179985 |
Sensitive |
| ENSG00000261131.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.020280427 |
Sensitive |
| ENSG00000261596.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.048923726 |
Sensitive |
| ENSG00000268189.2 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.035848601 |
Sensitive |
| ENSG00000269439.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.034885478 |
Sensitive |
| ENSG00000271751.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.028161679 |
Sensitive |
| ENSG00000271789.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.04532246 |
Sensitive |
| ENSG00000271888.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.027326659 |
Sensitive |
| ENSG00000272198.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.027234959 |
Sensitive |
| ENSG00000272872.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.045437544 |
Sensitive |
| ENSG00000273424.1 |
PF-562271 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016623995 |
Sensitive |
| ENSG00000204706.10 |
PF-562271 |
Pancreatic adenocarcinoma |
0.025562024 |
Sensitive |
| ENSG00000219665.4 |
PF-562271 |
Pancreatic adenocarcinoma |
0.011344997 |
Sensitive |
| ENSG00000223784.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.046820201 |
Sensitive |
| ENSG00000227674.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.018081877 |
Sensitive |
| ENSG00000229373.4 |
PF-562271 |
Pancreatic adenocarcinoma |
0.040269751 |
Sensitive |
| ENSG00000231999.2 |
PF-562271 |
Pancreatic adenocarcinoma |
0.007303012 |
Sensitive |
| ENSG00000234753.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.031242231 |
Sensitive |
| ENSG00000235488.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.007547727 |
Sensitive |
| ENSG00000237513.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.049282447 |
Sensitive |
| ENSG00000246731.2 |
PF-562271 |
Pancreatic adenocarcinoma |
0.001459144 |
Sensitive |
| ENSG00000247199.3 |
PF-562271 |
Pancreatic adenocarcinoma |
0.029721581 |
Sensitive |
| ENSG00000247556.2 |
PF-562271 |
Pancreatic adenocarcinoma |
0.045415846 |
Sensitive |
| ENSG00000248693.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.007923985 |
Sensitive |
| ENSG00000249868.4 |
PF-562271 |
Pancreatic adenocarcinoma |
0.009750283 |
Sensitive |
| ENSG00000254162.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.002421877 |
Sensitive |
| ENSG00000255145.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.015516537 |
Sensitive |
| ENSG00000257027.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.038715299 |
Sensitive |
| ENSG00000257058.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.037067046 |
Sensitive |
| ENSG00000258479.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.049925797 |
Sensitive |
| ENSG00000259398.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.027519794 |
Sensitive |
| ENSG00000259792.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.040633015 |
Sensitive |
| ENSG00000260317.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.045173218 |
Sensitive |
| ENSG00000268307.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.013610245 |
Sensitive |
| ENSG00000268583.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.023387857 |
Sensitive |
| ENSG00000270145.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.016674729 |
Sensitive |
| ENSG00000272003.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.039792566 |
Sensitive |
| ENSG00000272904.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.041448528 |
Sensitive |
| ENSG00000273416.1 |
PF-562271 |
Pancreatic adenocarcinoma |
0.036049857 |
Sensitive |
| ENSG00000205913.2 |
PF-562271 |
Sarcoma |
0.038108269 |
Sensitive |
| ENSG00000213742.2 |
PF-562271 |
Sarcoma |
0.009663798 |
Sensitive |
| ENSG00000224635.1 |
PF-562271 |
Sarcoma |
0.003509741 |
Sensitive |
| ENSG00000225113.1 |
PF-562271 |
Sarcoma |
0.003155019 |
Sensitive |
| ENSG00000225981.1 |
PF-562271 |
Sarcoma |
0.01491938 |
Sensitive |
| ENSG00000226155.1 |
PF-562271 |
Sarcoma |
0.049968589 |
Sensitive |
| ENSG00000226645.1 |
PF-562271 |
Sarcoma |
0.014162873 |
Sensitive |
| ENSG00000226913.1 |
PF-562271 |
Sarcoma |
0.009585004 |
Sensitive |
| ENSG00000229587.2 |
PF-562271 |
Sarcoma |
0.004808676 |
Sensitive |
| ENSG00000229591.1 |
PF-562271 |
Sarcoma |
0.034881664 |
Sensitive |
| ENSG00000229848.1 |
PF-562271 |
Sarcoma |
0.042734202 |
Sensitive |
| ENSG00000231611.1 |
PF-562271 |
Sarcoma |
0.036514406 |
Sensitive |
| ENSG00000232233.1 |
PF-562271 |
Sarcoma |
0.049550933 |
Sensitive |
| ENSG00000235117.2 |
PF-562271 |
Sarcoma |
0.011559679 |
Sensitive |
| ENSG00000235138.1 |
PF-562271 |
Sarcoma |
0.049327854 |
Sensitive |
| ENSG00000235527.2 |
PF-562271 |
Sarcoma |
0.008632486 |
Sensitive |
| ENSG00000237187.4 |
PF-562271 |
Sarcoma |
0.00890098 |
Sensitive |
| ENSG00000237438.2 |
PF-562271 |
Sarcoma |
0.048668838 |
Sensitive |
| ENSG00000237646.1 |
PF-562271 |
Sarcoma |
0.006842769 |
Sensitive |
| ENSG00000237892.1 |
PF-562271 |
Sarcoma |
0.011418356 |
Sensitive |
| ENSG00000240006.1 |
PF-562271 |
Sarcoma |
0.027835169 |
Sensitive |
| ENSG00000241481.2 |
PF-562271 |
Sarcoma |
0.037995615 |
Sensitive |
| ENSG00000242078.1 |
PF-562271 |
Sarcoma |
0.04361117 |
Sensitive |
| ENSG00000247679.2 |
PF-562271 |
Sarcoma |
0.019221247 |
Sensitive |
| ENSG00000248240.1 |
PF-562271 |
Sarcoma |
0.009683851 |
Sensitive |
| ENSG00000249602.1 |
PF-562271 |
Sarcoma |
0.000261205 |
Sensitive |
| ENSG00000250900.2 |
PF-562271 |
Sarcoma |
0.014658524 |
Sensitive |
| ENSG00000253197.1 |
PF-562271 |
Sarcoma |
0.02345655 |
Sensitive |
| ENSG00000255989.1 |
PF-562271 |
Sarcoma |
0.019785713 |
Sensitive |
| ENSG00000257256.1 |
PF-562271 |
Sarcoma |
0.039108134 |
Sensitive |
| ENSG00000257808.1 |
PF-562271 |
Sarcoma |
0.004126909 |
Sensitive |
| ENSG00000258048.1 |
PF-562271 |
Sarcoma |
0.000314264 |
Sensitive |
| ENSG00000258096.1 |
PF-562271 |
Sarcoma |
0.046922805 |
Sensitive |
| ENSG00000259618.1 |
PF-562271 |
Sarcoma |
0.044094785 |
Sensitive |
| ENSG00000260006.1 |
PF-562271 |
Sarcoma |
0.041367418 |
Sensitive |
| ENSG00000260176.1 |
PF-562271 |
Sarcoma |
0.047751041 |
Sensitive |
| ENSG00000260351.1 |
PF-562271 |
Sarcoma |
0.022856804 |
Sensitive |
| ENSG00000260448.1 |
PF-562271 |
Sarcoma |
0.001508452 |
Sensitive |
| ENSG00000260534.1 |
PF-562271 |
Sarcoma |
0.035588022 |
Sensitive |
| ENSG00000260735.1 |
PF-562271 |
Sarcoma |
0.023860974 |
Sensitive |
| ENSG00000260871.1 |
PF-562271 |
Sarcoma |
0.041946761 |
Sensitive |
| ENSG00000261101.1 |
PF-562271 |
Sarcoma |
0.000905409 |
Sensitive |
| ENSG00000261195.1 |
PF-562271 |
Sarcoma |
0.007408423 |
Sensitive |
| ENSG00000261512.2 |
PF-562271 |
Sarcoma |
0.016600446 |
Sensitive |
| ENSG00000261889.1 |
PF-562271 |
Sarcoma |
0.01743396 |
Sensitive |
| ENSG00000262482.1 |
PF-562271 |
Sarcoma |
0.04592938 |
Sensitive |
| ENSG00000267667.1 |
PF-562271 |
Sarcoma |
0.038508984 |
Sensitive |
| ENSG00000268650.3 |
PF-562271 |
Sarcoma |
0.028531969 |
Sensitive |
| ENSG00000269947.1 |
PF-562271 |
Sarcoma |
0.006564721 |
Sensitive |
| ENSG00000270039.1 |
PF-562271 |
Sarcoma |
0.041499213 |
Sensitive |
| ENSG00000270102.1 |
PF-562271 |
Sarcoma |
0.024802815 |
Sensitive |
| ENSG00000271185.1 |
PF-562271 |
Sarcoma |
0.038322013 |
Sensitive |
| ENSG00000272109.1 |
PF-562271 |
Sarcoma |
0.02985141 |
Sensitive |
| ENSG00000272609.1 |
PF-562271 |
Sarcoma |
0.033471674 |
Sensitive |
| ENSG00000273174.1 |
PF-562271 |
Sarcoma |
0.043686941 |
Sensitive |
| ENSG00000273203.1 |
PF-562271 |
Sarcoma |
0.040765439 |
Sensitive |
| ENSG00000168367.5 |
PF-562271 |
Skin cutaneous melanoma |
0.035917797 |
Sensitive |
| ENSG00000184324.11 |
PF-562271 |
Skin cutaneous melanoma |
0.00121971 |
Sensitive |
| ENSG00000197463.8 |
PF-562271 |
Skin cutaneous melanoma |
0.004891263 |
Sensitive |
| ENSG00000203875.6 |
PF-562271 |
Skin cutaneous melanoma |
0.007470479 |
Sensitive |
| ENSG00000205628.2 |
PF-562271 |
Skin cutaneous melanoma |
0.001928025 |
Sensitive |
| ENSG00000224271.1 |
PF-562271 |
Skin cutaneous melanoma |
0.039570941 |
Sensitive |
| ENSG00000225518.2 |
PF-562271 |
Skin cutaneous melanoma |
0.047521489 |
Sensitive |
| ENSG00000225656.1 |
PF-562271 |
Skin cutaneous melanoma |
0.021473473 |
Sensitive |
| ENSG00000228201.1 |
PF-562271 |
Skin cutaneous melanoma |
0.017555719 |
Sensitive |
| ENSG00000229776.1 |
PF-562271 |
Skin cutaneous melanoma |
0.035245056 |
Sensitive |
| ENSG00000231447.1 |
PF-562271 |
Skin cutaneous melanoma |
0.014634498 |
Sensitive |
| ENSG00000232876.1 |
PF-562271 |
Skin cutaneous melanoma |
0.015982789 |
Sensitive |
| ENSG00000233893.1 |
PF-562271 |
Skin cutaneous melanoma |
0.030783073 |
Sensitive |
| ENSG00000234584.1 |
PF-562271 |
Skin cutaneous melanoma |
0.000780643 |
Sensitive |
| ENSG00000234753.1 |
PF-562271 |
Skin cutaneous melanoma |
0.001962126 |
Sensitive |
| ENSG00000235760.3 |
PF-562271 |
Skin cutaneous melanoma |
0.000954209 |
Sensitive |
| ENSG00000235910.1 |
PF-562271 |
Skin cutaneous melanoma |
0.016451846 |
Sensitive |
| ENSG00000248774.1 |
PF-562271 |
Skin cutaneous melanoma |
0.005839013 |
Sensitive |
| ENSG00000249249.1 |
PF-562271 |
Skin cutaneous melanoma |
0.023012693 |
Sensitive |
| ENSG00000254526.1 |
PF-562271 |
Skin cutaneous melanoma |
0.008737633 |
Sensitive |
| ENSG00000254532.1 |
PF-562271 |
Skin cutaneous melanoma |
0.022341668 |
Sensitive |
| ENSG00000258099.1 |
PF-562271 |
Skin cutaneous melanoma |
0.049486344 |
Sensitive |
| ENSG00000258101.1 |
PF-562271 |
Skin cutaneous melanoma |
0.013820244 |
Sensitive |
| ENSG00000258689.1 |
PF-562271 |
Skin cutaneous melanoma |
0.032906369 |
Sensitive |
| ENSG00000260289.1 |
PF-562271 |
Skin cutaneous melanoma |
0.049289242 |
Sensitive |
| ENSG00000260366.1 |
PF-562271 |
Skin cutaneous melanoma |
0.044010236 |
Sensitive |
| ENSG00000261392.1 |
PF-562271 |
Skin cutaneous melanoma |
0.018099042 |
Sensitive |
| ENSG00000261513.1 |
PF-562271 |
Skin cutaneous melanoma |
0.00679003 |
Sensitive |
| ENSG00000261773.1 |
PF-562271 |
Skin cutaneous melanoma |
0.025547937 |
Sensitive |
| ENSG00000266654.1 |
PF-562271 |
Skin cutaneous melanoma |
0.034027849 |
Sensitive |
| ENSG00000266677.1 |
PF-562271 |
Skin cutaneous melanoma |
0.033553021 |
Sensitive |
| ENSG00000267342.1 |
PF-562271 |
Skin cutaneous melanoma |
0.006144386 |
Sensitive |
| ENSG00000268307.1 |
PF-562271 |
Skin cutaneous melanoma |
0.040251874 |
Sensitive |
| ENSG00000271127.1 |
PF-562271 |
Skin cutaneous melanoma |
0.038807647 |
Sensitive |
| ENSG00000272983.1 |
PF-562271 |
Skin cutaneous melanoma |
0.020373403 |
Sensitive |
| ENSG00000212978.5 |
PF-562271 |
Thyroid carcinoma |
0.022894926 |
Sensitive |
| ENSG00000214407.3 |
PF-562271 |
Thyroid carcinoma |
0.022029235 |
Sensitive |
| ENSG00000223478.1 |
PF-562271 |
Thyroid carcinoma |
0.035370209 |
Sensitive |
| ENSG00000223485.1 |
PF-562271 |
Thyroid carcinoma |
0.040349696 |
Sensitive |
| ENSG00000223734.2 |
PF-562271 |
Thyroid carcinoma |
0.036900385 |
Sensitive |
| ENSG00000225981.1 |
PF-562271 |
Thyroid carcinoma |
0.010007543 |
Sensitive |
| ENSG00000226312.3 |
PF-562271 |
Thyroid carcinoma |
0.017959233 |
Sensitive |
| ENSG00000226386.1 |
PF-562271 |
Thyroid carcinoma |
0.010265509 |
Sensitive |
| ENSG00000226455.1 |
PF-562271 |
Thyroid carcinoma |
0.0085462 |
Sensitive |
| ENSG00000226637.1 |
PF-562271 |
Thyroid carcinoma |
0.018588848 |
Sensitive |
| ENSG00000227574.2 |
PF-562271 |
Thyroid carcinoma |
0.012862897 |
Sensitive |
| ENSG00000227906.3 |
PF-562271 |
Thyroid carcinoma |
0.033307619 |
Sensitive |
| ENSG00000229065.1 |
PF-562271 |
Thyroid carcinoma |
0.040692726 |
Sensitive |
| ENSG00000229951.1 |
PF-562271 |
Thyroid carcinoma |
0.049758425 |
Sensitive |
| ENSG00000230084.1 |
PF-562271 |
Thyroid carcinoma |
0.014804104 |
Sensitive |
| ENSG00000230695.1 |
PF-562271 |
Thyroid carcinoma |
0.041811554 |
Sensitive |
| ENSG00000231290.1 |
PF-562271 |
Thyroid carcinoma |
0.047407086 |
Sensitive |
| ENSG00000233242.2 |
PF-562271 |
Thyroid carcinoma |
0.006282377 |
Sensitive |
| ENSG00000233912.1 |
PF-562271 |
Thyroid carcinoma |
0.024271299 |
Sensitive |
| ENSG00000236658.1 |
PF-562271 |
Thyroid carcinoma |
0.003275438 |
Sensitive |
| ENSG00000238058.1 |
PF-562271 |
Thyroid carcinoma |
0.021570571 |
Sensitive |
| ENSG00000238113.2 |
PF-562271 |
Thyroid carcinoma |
0.007282799 |
Sensitive |
| ENSG00000241280.1 |
PF-562271 |
Thyroid carcinoma |
0.024816761 |
Sensitive |
| ENSG00000241732.1 |
PF-562271 |
Thyroid carcinoma |
0.03756588 |
Sensitive |
| ENSG00000247095.2 |
PF-562271 |
Thyroid carcinoma |
0.031043387 |
Sensitive |
| ENSG00000248323.1 |
PF-562271 |
Thyroid carcinoma |
0.020130858 |
Sensitive |
| ENSG00000248896.2 |
PF-562271 |
Thyroid carcinoma |
0.040428918 |
Sensitive |
| ENSG00000248925.1 |
PF-562271 |
Thyroid carcinoma |
0.00389355 |
Sensitive |
| ENSG00000249867.1 |
PF-562271 |
Thyroid carcinoma |
0.031672125 |
Sensitive |
| ENSG00000251221.1 |
PF-562271 |
Thyroid carcinoma |
0.024157527 |
Sensitive |
| ENSG00000253553.1 |
PF-562271 |
Thyroid carcinoma |
0.002853834 |
Sensitive |
| ENSG00000253642.1 |
PF-562271 |
Thyroid carcinoma |
0.046810587 |
Sensitive |
| ENSG00000254473.1 |
PF-562271 |
Thyroid carcinoma |
0.039304078 |
Sensitive |
| ENSG00000254671.1 |
PF-562271 |
Thyroid carcinoma |
0.029384187 |
Sensitive |
| ENSG00000255029.1 |
PF-562271 |
Thyroid carcinoma |
0.002123128 |
Sensitive |
| ENSG00000255240.1 |
PF-562271 |
Thyroid carcinoma |
0.027869385 |
Sensitive |
| ENSG00000256377.1 |
PF-562271 |
Thyroid carcinoma |
0.035727758 |
Sensitive |
| ENSG00000256452.1 |
PF-562271 |
Thyroid carcinoma |
0.011383092 |
Sensitive |
| ENSG00000257831.1 |
PF-562271 |
Thyroid carcinoma |
0.027915146 |
Sensitive |
| ENSG00000259103.1 |
PF-562271 |
Thyroid carcinoma |
0.023449333 |
Sensitive |
| ENSG00000259877.1 |
PF-562271 |
Thyroid carcinoma |
0.009810891 |
Sensitive |
| ENSG00000259883.1 |
PF-562271 |
Thyroid carcinoma |
0.018586375 |
Sensitive |
| ENSG00000260464.1 |
PF-562271 |
Thyroid carcinoma |
0.049887525 |
Sensitive |
| ENSG00000260742.1 |
PF-562271 |
Thyroid carcinoma |
0.017467619 |
Sensitive |
| ENSG00000261253.1 |
PF-562271 |
Thyroid carcinoma |
0.016305013 |
Sensitive |
| ENSG00000262313.1 |
PF-562271 |
Thyroid carcinoma |
0.030056828 |
Sensitive |
| ENSG00000262619.1 |
PF-562271 |
Thyroid carcinoma |
0.029132235 |
Sensitive |
| ENSG00000263293.1 |
PF-562271 |
Thyroid carcinoma |
0.046872864 |
Sensitive |
| ENSG00000266601.1 |
PF-562271 |
Thyroid carcinoma |
0.049396489 |
Sensitive |
| ENSG00000266850.1 |
PF-562271 |
Thyroid carcinoma |
0.039332755 |
Sensitive |
| ENSG00000267272.1 |
PF-562271 |
Thyroid carcinoma |
0.035951787 |
Sensitive |
| ENSG00000267289.1 |
PF-562271 |
Thyroid carcinoma |
0.043978997 |
Sensitive |
| ENSG00000267316.1 |
PF-562271 |
Thyroid carcinoma |
0.006903896 |
Sensitive |
| ENSG00000267498.1 |
PF-562271 |
Thyroid carcinoma |
0.016828595 |
Sensitive |
| ENSG00000268573.1 |
PF-562271 |
Thyroid carcinoma |
0.032581816 |
Sensitive |
| ENSG00000268584.1 |
PF-562271 |
Thyroid carcinoma |
0.01657196 |
Sensitive |
| ENSG00000269082.1 |
PF-562271 |
Thyroid carcinoma |
0.006071418 |
Sensitive |
| ENSG00000271762.1 |
PF-562271 |
Thyroid carcinoma |
0.005367018 |
Sensitive |
| ENSG00000271826.1 |
PF-562271 |
Thyroid carcinoma |
0.006515016 |
Sensitive |
| ENSG00000272033.1 |
PF-562271 |
Thyroid carcinoma |
0.019769688 |
Sensitive |
| ENSG00000272463.1 |
PF-562271 |
Thyroid carcinoma |
0.005871928 |
Sensitive |
| ENSG00000272518.1 |
PF-562271 |
Thyroid carcinoma |
0.03229674 |
Sensitive |
| ENSG00000272659.1 |
PF-562271 |
Thyroid carcinoma |
0.045365895 |
Sensitive |
| ENSG00000272858.1 |
PF-562271 |
Thyroid carcinoma |
0.047634039 |
Sensitive |
| ENSG00000272902.1 |
PF-562271 |
Thyroid carcinoma |
0.048186364 |
Sensitive |
| ENSG00000272949.1 |
PF-562271 |
Thyroid carcinoma |
0.001570901 |
Sensitive |
| ENSG00000272983.1 |
PF-562271 |
Thyroid carcinoma |
0.036063689 |
Sensitive |
| ENSG00000273471.1 |
PF-562271 |
Thyroid carcinoma |
0.0480909 |
Sensitive |
